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Abstract 
 
Intracranial aneurysms are treated by either microsurgical clipping or endovascular 
coiling (i.e. embolization), the latter being a much newer treatment method. Thus, 
long-term outcome studies after endovascular coiling are still sparse. In addition, 
imaging modalities are more and more frequently used to study patients for many 
different reasons, and unruptured intracranial aneurysms are detected incidentally. 
Treatment of those incidentally found unruptured aneurysms is debated a lot 
because complication rate after both clipping and coiling is high, risk of bleeding is 
low and we still do not know which aneurysms will eventually rupture.  In spite of 
highly developed imaging methods, there are still patients with subarachnoid 
bleeding without any etiological factor. This bleeding of unknown etiology has been 
studied much less than aneurysmal disease in recent years. The aim of this thesis 
was to determine the long-term outcome of patients treated with embolization and 
patients with subarachnoid hemorrhage (SAH) of unknown etiology. 
This study is based on 1294 patients treated in Tampere University Hospital 
during 1989-1999. Surviving patients treated with endovascular coiling (n=185) and 
patients with SAH of unknown etiology (n=97) were studied with magnetic 
resonance imaging (MRI) 9-18 years (median 9 yrs, mean 11yrs) after 
hospitalization and the clinical outcome of all treated patients was assessed.  
Patients with previous SAH of unknown etiology have a good clinical outcome 
with no vascular changes in MR-images and they have no excess mortality 
compared to matched general population. Patients with unruptured aneurysms, 
however, have excess long-term mortality, especially if the aneurysm is left 
untreated. Both ruptured and unruptured intracranial aneurysms are stable in long-
term MRI studies but complete occlusion should be the goal of the treatment to 
prevent rebleedings. Brain infarctions without clinical consequences are common 
after embolization.   
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Tiivistelmä 
 
Aivovaltimon pullistumia (aneurysma) hoidetaan sekä kallonavausleikkauksella että 
suonensisäisesti embolisoimalla. Embolisaatio on menetelmänä selvästi uudempi ja 
sen vuoksi hoitomuodon pitkäaikaistuloksia ei juuri ole julkaistu. Myös 
kuvantamistekniikat ovat kehittyneet viime vuosina ja sen vuoksi sattumalta 
löydettyjen aneurysmien määrä on lisääntynyt. Näiden sattumalöydösaneurysmien 
hoidosta kiistellään, sillä hoitoon liittyvät riskit ovat joissain tutkimuksissa 
suurempia kuin aneurysman puhkeamisriski. Vaikka aivoverisuonten 
kuvantamismenetelmät ovat kehittyneet, on edelleen potilaita, joiden 
lukinkalvonalaiselle verenvuodolle (subaraknoidaalivuoto, SAV) ei löydy syytä. 
Tämän väitöstutkimuksen tavoite oli selvittää aneurysma- ja SAV-potilaiden 
pitkäaikaisennustetta ja kuvantamislöydöksiä lähes 10 vuoden seuranta-aikana. 
Tutkimusaineisto koostui 1294 SAV- ja aneurysmapotilaasta, jotka olivat 
hoidossa Tampereen yliopistollisessa sairaalassa vuosina 1989-1999.  Potilaat, joita 
oli hoidettu suonensisäisesti embolisoimalla (n=185) tai jotka olivat olleet hoidossa 
etiologialtaan epäselväksi jääneen subaraknoidaalivuodon vuoksi (n=97), kutsuttiin 
uuteen pään magneettitutkimukseen. Magneettikuvaus tehtiin keskimäärin 11 vuotta 
(9-18 vuotta) primaarihoidon jälkeen ja lisäksi kaikkien potilaiden toipuminen 
arvioitiin.  
Potilaat, joiden SAV:n syy ei selvinnyt, toipuivat hyvin ja pitkäaikaiskuolleisuus 
oli normaaliväestön tasolla. Magneettikuvissa ei löytynyt poikkeavia 
suonirakenteita, jotka olisivat selittäneet aiempaa vuotoa. Vuotamattoman 
aneurysman omaavilla potilailla on lisääntynyttä pitkäaikaiskuolleisuutta erityisesti, 
jos aneurysma on jätetty hoitamatta. Potilailla on suurempi riski sydän-ja 
verisuonitautikuolemiin kuin normaaliväestöllä. Vuotaneet aneurysmat säilyttävät 
hoitotuloksen pitkäaikaisseurannassa mutta embolisaatiossa pitäisi pyrkiä 
aneurysman kokonaistäyttöön uusintavuotojen estämiseksi.  Aivoinfarkti on yleinen 
embolisaation komplikaatio kuvantamistutkimuksissa, mutta vain harvoin aiheuttaa 
kliinisiä oireita.  
 
 
7 
Abstrakt 
 
Hjärnaneurysm kan behandlas kirurgiskt genom kraniotomi eller med endovaskulär 
ocklusion. Eftersom endovaskulär ocklusion är en nyare behandlingsform finns få 
studier om metodens långtidseffekter. I och med snabb utveckling av radiologiska 
undersökningsmetoder har det skett en ökning av antalet aneurysm som upptäcks 
slumpmässigt. Åsikterna om hur dessa slumpmässigt upptäckta aneurysm bör 
behandlas varierar stort. Vissa undersökningsresultat tyder på att behandling av 
dessa aneurysm medför en större komplikation risk än risken för ruptur av 
aneurysmet. Även om de radiologiska undersökningsmetoderna av hjärnans blodkärl 
är avancerade finns det fortfarande patienter där orsaken till 
subaraknoidalblödningen (SAB) inte kan påvisas. Målet med denna avhandling var 
att undersöka långtidsprognosen av aneurysm- och SAB-patienter samt deras 
radiologiska fynd under en nästan tio års uppföljningstid. 
 Materialet för undersökningen bestod av 1294 patienter som behandlats på 
Tammerfors universitetssjukhus under åren 1989-1999 på grund av SAB och 
aneurysm. De patienter som behandlats genom endovaskulär ocklusion (n=185) 
eller som behandlats för SAB av oklar etiologi (n=97) kallades för ny 
magnetundersökning av hjärnan. Magnetundersökningen gjordes i genomsnitt 11 år 
(9-18 år) efter det initiala vårdtillfället. Dessutom bedömdes alla patienters 
återhämtning efter given behandling.  
 De patienter som behandlats för SAB av oklar etiologi visade sig i studien ha 
återhämtat sig bra och långtidsmortaliteten motsvarade normalbefolkningens. I 
magnetkameraundersökningen konstaterades inga blodkärlsförändringar som hade 
kunnat förklara den tidigare blödningen. Däremot uppvisade patienter med 
konstaterat obrustet aneurysm en högre långtidsmortalitet, vilket i synnerhet gällde 
om aneurysmet lämnats obehandlat. Dessa patienter löper en större risk att avlida i 
hjärt- och kärlsjukdom än normalbefolkningen. Aneurysm som brustit och som 
behandlats med endovaskulär ocklusion uppvisade goda resultat i 
långtidsuppföljningen. För att undvika nya blödningar bör man eftersträva 
fullständig ocklusion av aneurysmet. Radiologiskt konstaterad hjärninfarkt är en 
vanlig komplikation efter endovaskulär ocklusion av aneurysm, men leder sällan till 
kliniska symptom. 
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1. Introduction 
Aneurysmal subarachnoid hemorrhage (SAH) has high mortality due to bleeding 
itself, vasospasm and possible rebleeding before occlusion. Approximately 50% of 
SAH patients still die in spite of modern diagnostic and treatment methods (Ingall et 
al., 1989; Sarti et al., 1991; Broderick et al., 1994; Hop et al., 1997; Inagawa, 1997; 
Inagawa, 2001; Pobereskin, 2001; Stegmayr et al., 2004; Inagawa, 2005; Pajunen et 
al., 2005). Early treatment is preferable to prevent rebleeding and also to give the 
opportunity to implement intensive and safe vasospasm treatment (Ohman and 
Heiskanen, 1989). Endovascular coiling started two decades ago and is widely used 
nowadays. Coiling has been found to be safe and sufficient to prevent rebleeding 
after aneurysmal SAH, although the rebleeding rate is higher after coiling than 
clipping (Raymond and Roy, 1997; Vinuela et al., 1997; Byrne et al., 1999; 
Molyneux et al., 2009). However, patients with coiled aneurysms do have better 
clinical recovery than patients treated with microsurgical clipping (Molyneux et al., 
2005; Molyneux et al., 2009). Long-term outcome studies after endovascular coiling 
have been limited because this is a relatively new treatment method.  
Treatment of unruptured aneurysms has recently been discussed a lot 
because treatment morbidity is still relatively high and speculated to be higher than 
the risk of rupture of small incidental aneurysms (Juvela et al., 1993; Juvela et al., 
2000; Wiebers et al., 2003). Further, although aneurysm rupture risk correlates to 
the aneurysm size, most ruptured aneurysms are small, less than 7mm. Thus, 
mechanisms of rupture and long-term outcome following different treatment 
methods have to be studied further.  
SAH is usually caused by a rupture of intracranial, saccular aneurysm. In 5-
15% of cases no cause of bleeding can be found despite repeated angiographic 
studies. Such SAH of unknown etiology is less studied than aneurysmal bleeding 
and the benign nature of this entity is based more on clinical experience than 
evidence-based medicine.  
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2. Review of the literature 
2.1 Aneurysmal subarachnoid hemorrhage (SAH) 
Intracranial saccular aneurysms account for approximately 85% of cases of 
nontraumatic SAH (Kassell et al., 1990b; van Gijn and Rinkel, 2001; van Gijn et al., 
2007). The other, rare, causes are listed in Table 1. Despite repeated angiographies, 
no source of bleeding is identified in up to 15% of SAH cases (Ruigrok et al., 2000). 
This entity “SAH of unknown etiology” is discussed separately at the end of this 
literature review.  
2.1.1 Aneurysm characteristics 
2.1.1.1 Classification 
An aneurysm is a localized and persistent out-poutching of the vessel. Aneurysms 
can be divided into saccular and non-saccular types and saccular aneurysm account 
for more than 85% of all intracranial aneurysms (Kassell et al., 1990b; van Gijn and 
Rinkel, 2001; van Gijn et al., 2007). Saccular aneurysms involve part of the 
circumference of the artery arising from vascular bifurcations, or from the side of a 
vessel, and they have a single neck. Saccular aneurysms can arise as solitary (70-
75%) or multiple (25-30%) lesions. Cerebral aneurysms are rare in children: 2% of 
SAH patients are under 19 and only 0.1% are under 5 years old (Heiskanen, 1989; 
Koroknay-Pál et al., 2012).  Nonsaccular aneurysms involve the entire arterial wall 
and do not have a neck. Non-saccular aneurysms can be divided into several types: 
fusiform, dissecting, mycotic, flow-related and traumatic aneurysms. 
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Table 1. Rare causes of subarachnoid hemorrhage. Adapted from van Gijn et al. 
(2007). 
Non-inflammatory lesions of intracerebral vessels 
 Arterial dissection 
 Arteriovenous malformation 
 Dural fistulae 
 Intracerebral cavernous angiomas 
 Cerebral venous thrombosis 
 Cerebral amyloid angiopathy 
 Moyamoya disease 
Inflammatory lesions of cerebral arteries 
 Behçet’s disease 
 Primary angiitis 
 Polyarteritis nodosa 
 Churg-Strauss syndrome 
 Wegener’s granulomatosis 
Infectious (mycotic) aneurysms 
 Bacterial aneurysms (Streptococcus, Stafylococcus, Enterococcus) 
            Fungal aneurysms (Aspergillus, Candida) 
Vascular lesions in the spinal cord 
 Saccular aneurysm of spinal artery 
 Spinal arteriovenous fistula or malformation 
 Cavernous angioma at spinal level 
Sickle cell disease, coagulopathies 
Tumours 
 Pituitary apoplexy 
 Cerebral metastases of cardiac myxoma 
 Malignant glioma 
 Angiolipoma 
 Schwannoma of cranial nerve 
 Cervical meningiomas 
 Cervical spinal cord hemangioblastoma 
 Spinal meningeal carcinomatosis 
Radiation-induced aneurysms 
Drugs 
 Cocaine abuse 
 Anticoagulant drugs 
Trauma 
 Direct injury to the arterial wall 
 Acceleration-induced shear 
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2.1.1.2 Location 
The majority of aneurysms arise at the bifurcation of arteries near the circle of 
Willis and most, about 85% arise in the anterior circulation. The most common sites 
of ruptured aneurysms are the takeoff of the posterior communicating artery (ACoP) 
from the internal carotid artery (ICA, 24-41%), anterior communicating artery 
(ACoA)/ anterior cerebral artery (ACA, 30-39%), and middle cerebral artery (MCA, 
20-33%) (Wiebers et al., 2003; Clarke et al., 2005). However, in the Finnish 
population, MCA aneurysms have predominance compared to other locations; up to 
35% of ruptured aneurysms and 57% of unruptured aneurysms are located in MCA 
(Rinne et al., 1994; Huttunen et al., 2010). Approximately 15% of aneurysms occur 
in the posterior, vertebro-basilar, circulation (Clarke et al., 2005). Table 2 shows 
aneurysm location distribution in a Finnish study (Huttunen et al., 2010).  
 
 
 
Table 2. Location of intracranial aneurysms adapted from Huttunen et al. (2010). 
 
 Ruptured Unruptured 
 n % n % 
ICA bifurcation 41  4 50 4 
ACoP 153 13 93 8 
ACoA 369 32 152 13 
ACA 76 7 87 8 
MCA 404 35 651 57 
VBA 119 10 113 10 
Total 1162  1146  
 
ACA=Anterior cerebral artery; ACoA=Anterior communicating artery; ACoP=Posterior 
communicating artery; ICA=Internal carotid artery; MCA=Middle cerebral artery; VBA= 
Vertebrobasilar artery 
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2.1.1.3 Size 
Aneurysms are usually defined as small (<10 mm), large (10–25 mm), or giant (>25 
mm) on the basis of their maximum fundus dimension. Giant aneurysms account for 
4-8% of intracranial aneurysms (Vinuela et al., 1997). Giant aneurysms rupture 
more often than smaller aneurysms and they are also more often symptomatic 
because of mass effect or thromboembolic events caused by aneurysm thrombosis 
(Wiebers et al., 1981; Investigators, 1998; Rinkel et al., 1998; Forget et al., 2001; 
Juvela et al., 2001; Wiebers et al., 2003). Although risk of aneurysm rupture 
correlates to the aneurysm size, up to 86% of  ruptured aneurysms are small, less 
than 10mm (Rinkel et al., 1998; Forget et al., 2001). Table 3 presents size relations 
from a study of Forget et al. (2001).   
 
Table 3. Sizes of ruptured aneurysms (Forget et al., 2001). 
 
Fundus size n % 
<5mm  86 35 
6–10mm  124 51 
11–15mm  17 7 
16–20mm 6 2 
21-25mm 3 1 
>25mm  9 4 
2.1.2 Epidemiology of intracranial aneurysms 
2.1.2.1 Incidence 
The overall incidence of aneurysmal SAH is approximately 9 (6-12) per 100 000 
persons-years in western countries (Sarti et al., 1991; Broderick et al., 1994; Ostbye 
et al., 1997; Cesarini et al., 1999; Anderson et al., 2000; Ingall et al., 2000; Inagawa, 
2001; Pobereskin, 2001; van Gijn and Rinkel, 2001; de Rooij et al., 2007; van Gijn 
et al., 2007; Koffijberg et al., 2008). However, rates are much higher in Finland and 
Japan which range from 17 up to 37/100000 (Sarti et al., 1991; Broderick et al., 
1994; Ostbye et al., 1997; Cesarini et al., 1999; Ingall et al., 2000; Inagawa, 2001; 
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Pobereskin, 2001; de Rooij et al., 2007; Koffijberg et al., 2008). The decline in 
incidence of SAH over the past decades is moderate compared with that for strokes 
in general (de Rooij et al., 2007).  
2.1.2.2 Prevalence 
In autopsy and radiological studies, the prevalence of intracranial aneurysms in the 
general population is around 2% (0.2-9%) (Rinkel et al., 1998; Ronkainen et al., 
1998). Most aneurysms never rupture and the prevalence is much higher than the 
incidence of SAH. Prevalence increases with age and is higher in females than in 
males, and in those with a family history of SAH (Ronkainen et al., 1993; 
Ronkainen et al., 1998; van Gijn et al., 2007).  
2.1.2.3 Risk factors for SAH 
The incidence of SAH increases with age to a peak in the fifth and sixth decades of 
life (Ingall et al., 2000). Thereafter, the incidence remains stable or even decreases 
slightly with further aging (Ingall et al., 2000). For unknown reasons the incidence 
of aneurysmal SAH in women is 1.2-1.6 times higher than in men (Ingall et al., 
1989; Ostbye et al., 1997; de Rooij et al., 2007; Koffijberg et al., 2008). This gender 
difference starts at age 55 years and increases thereafter (de Rooij et al., 2007; 
Koffijberg et al., 2008). Aneurysms in posterior circulation and anterior 
communicating artery have a higher rupture rate than aneurysms in other locations 
(Kaminogo et al., 2003; Clarke et al., 2005; Huttunen et al., 2010). ACoA 
aneurysms are responsible for approximately 40% of SAH in the Finnish population 
(Huttunen et al., 2010). Large and symptomatic aneurysms have higher rupture risk 
than smaller and asymptomatic lesions (Juvela et al., 1993; Juvela et al., 2000; 
Wiebers et al., 2003). Persons having close relatives with SAH and patients with 
autosomal dominant polycystic kidney disease have a higher risk for aneurysm 
formation than the general population (Ronkainen et al., 1997; Rinkel et al., 1998; 
Gieteling and Rinkel, 2003).  
Independent, acquired, risk factors for SAH include hypertension (relative risk 
2.5 to 2.6), cigarette smoking (relative risk, 2.2 to 3.1) and heavy alcohol 
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consumption (relative risk 1.5 to 2.1) (Rinkel et al., 1998; Juvela et al., 2000; Feigin 
et al., 2005; Sandvei et al., 2009). 
2.1.2.4 Familial factors 
In Finland, about 10% of SAH cases are familial, with at least two affected first 
degree family members harbouring aneurysms (Ronkainen et al., 1993; Ronkainen 
et al., 1997). Individuals with one affected first-degree relative have 3-4 times 
higher risk of harbouring an aneurysm than the general population (Schievink et al., 
1995a). Patients with two affected relatives have 7-10% lifetime risk for SAH 
(Ronkainen et al., 1997; Teasdale et al., 2005; van Gijn et al., 2007). Persons with 
familial intracranial aneurysms have an increased risk of aneurysm formation and 
rupture, and familial SAH patients are younger at the time of bleeding than patients 
with sporadic SAH (Wermer et al., 2006; van Gijn et al., 2007). Patients with 
familial intracranial aneurysms also have more multiple aneurysms and larger 
aneurysms than those with sporadic aneurysms (Wermer et al., 2006; van Gijn et al., 
2007). However, only a minority of familial SAH cases seem to be due to the 
clustering of susceptibility genes, but clustering of confounding risk factors might 
play a larger role in familial aneurysms (Korja M et al., 2010). A multistage 
genome-wide association study (GWAS) of Finnish, Japanese and Dutch cohorts 
identified five common SNPs associated with intracranial aneurysms on 
chromosomes 2q, 8q and 9p (Bilguvar et al., 2008). An aneurysm is detected in 16% 
of people with familial aneurysms, so screening of these patients is reasonable 
(Ronkainen et al., 1993; Wermer et al., 2006). In Finland, screening of first degree 
relatives of saccular aneurysm patients is performed in families with two first-
degree relatives with aneurysmal disease (Ronkainen et al., 1998; Jaaskelainen, 
2007).  
2.1.2.5 Multiple aneurysms 
Multiple aneurysms are detected in 8-34% of SAH patients (Broderick et al., 1994; 
Rinne et al., 1994; Raymond and Roy, 1997; Qureshi et al., 1998; Byrne et al., 
1999; Juvela, 2000; Kaminogo et al., 2003; Holmin et al., 2008; Diringer, 2009; 
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Huttunen et al., 2010). Smoking, female gender and hypertension increase the risk 
of multiple aneurysms (Rinne et al., 1994; Qureshi et al., 1998; Juvela, 2000; 
Kaminogo et al., 2003). A Finnish study comprising 114 patients showed that 
patients with multiple aneurysms had more carotid and pericallosal aneurysms 
compared to patients with one aneurysm (Rinne et al., 1994).  In patients with 
multiple aneurysms, it may be difficult to identify which aneurysm has bled. The 
localization of blood on the computed tomograghy (CT) scan can help to identify 
the aneurysm responsible for the SAH (Karttunen et al., 2003). Ruptured aneurysms 
are also usually the largest and the most irregular shaped and ACoA aneurysm in 
patients with multiple aneurysms is more prone to bleed than aneurysms at other 
locations (Kaminogo et al., 2003). 
2.1.3 Pathogenesis of intracranial aneurysms 
Most aneurysms are idiopathic with no specific etiology. A minority of aneurysms 
have a specific etiological factor, like dissecting aneurysms, infectious aneurysms or 
flow-related aneurysms, as stated in Table 1. Changes in cerebral vessel 
hemodynamics is considered predisposing aneurysm formation in acquired factors 
like cigarette smoking as well as in congenital deformities like polycystic kidneys 
(Juvela et al., 2001; Gieteling and Rinkel, 2003).   
The layers of intracranial arteries are adventitia (outer loose connective tissue), 
media (muscular layer) and intima (inner layer with smooth muscle cells and 
endothelial layer). The wall of the cerebral arteries is thinner than in peripheral 
arteries and thus has a higher rate of aneurysm development. The wall of the 
ruptured aneurysm is thinner than in unruptured aneurysms and the structure is 
disorganized with no clearly defined layers (Kataoka et al., 1999). There are also 
excess inflammatory cells compared to unruptured aneurysms. Before the aneurysm 
rupture, the wall undergoes morphological changes like apoptosis, de-
endothelialization, luminal thrombosis, smooth muscle cell proliferation, T-cell and 
macrophage infiltration and complement activation (Kataoka et al., 1999; Frosen et 
al., 2004; Tulamo et al., 2006).    
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2.1.4 Clinical presentation  
The classic presentation of acute aneurysm rupture is sudden headache, nausea, 
vomiting, nuchal rigidity and syncope, followed typically by a gradual improvement 
in level of consciousness (van Gijn et al., 2007). Focal neurological signs may be 
seen due to mass effect from a giant aneurysm, parenchymal hemorrhage or seldom 
due to a subdural hematoma (van Gijn et al., 2007). Third and sixth cranial nerve 
palsies may be present because of aneurysmal compression of the nerve or increased 
intracranial pressure, respectively (Diringer, 2009). Seizures may occur in up to 
20% of patients after SAH (Claassen et al., 2003; Bederson et al., 2009). 
Aneurysms located around the cavernous sinus may cause cranial nerve III-VI 
palsies or visual deficits, and ACoP aneurysms can cause third nerve palsy. 
Pericallosal aneurysms are rare, being only 6% of all aneurysms, and those are 
frequently associated with ICH, IVH and blood along the corpus callosum or 
anterior interhemispheric fissure (Lehecka et al., 2010).  
Hunt and Hess scale (H&H, Table 4) and the World Federation of Neurologic 
Surgeons (WFNS, Table 5) grading scales are the most frequently used to assess the 
clinical condition of SAH patients (Hunt and Hess, 1968; Report of World 
Federation of Neurological Surgeons Committee, 1988). 
 
 
Table 4. Hunt&Hess grading scale following subarachnoid hemorrhage (Hunt and 
Hess, 1968). 
 
Grade   
I  Asymptomatic or mild headache  
II  Moderate to severe headache, nuchal rigidity, with or without cranial nerve deficits 
III Confusion, lethargy, or mild focal symptoms  
IV  Stupor and/or hemiparesis  
V  Comatose and/or extensor posturing  
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Table 5. WFNS grading scale (Report of World Federation of Neurological Surgeons 
Committee, 1988). 
 
WFNS grade Glasgow Coma Scale Motor deficit 
I 15 Absent 
II 14-13 Absent 
III 14-13 Present 
IV 12-7 Present or absent 
V 6-3 Present or absent 
 
 
Increased cerebrospinal fluid pressure causes obstruction of the central retinal vein 
as it traverses the optic nerve sheath. This may cause intraocular hemorrhage and 
vision impairment. Preretinal hemorrhage extending into the vitreous body (Terson's 
syndrome) is seen in 13% of SAH patients (McCarron et al., 2004). It is detected 
more in poor-grade patients than in patients with good H&H grades (McCarron et 
al., 2004).  
Unruptured aneurysms are either detected after SAH from another aneurysm, or 
because of symptoms caused by the mass effect of the aneurysm, or are discovered 
during the screening for an incidental aneurysm or most often incidentally during 
neuroradiological imaging because of an unrelated medical condition such as 
cerebrovascular ischemia, headache, dizziness, head trauma etc. Unruptured 
aneurysms are most often asymptomatic, but those can cause neurological 
symptoms like pain, cranial nerve palsies, visual disturbances, seizure, vertigo or 
ischemic events due to thromboembolism. In a series of 269 patients with 
unruptured aneurysms, 3.3% of patients had ischemic strokes due to embolization 
from the aneurysmal sac (Qureshi et al., 2000). 
2.1.5 Diagnosis and imaging 
CT scanning is the first investigation if subarachnoid hemorrhage is suspected. A 
CT scan has 98-100% sensitivity for SAH in the first 12 hours after bleeding. 
Sensitivity decreases after several hours so that after one week it is only 50% (van 
Gijn and van Dongen, 1982; Edlow, 2005). Lumbar puncture and analysis of the 
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cerebrospinal fluid for xanthochromia is performed if the initial CT scan is negative 
(Zacharia et al., 2010).  
CT is not always performed immediately after the insult and there can be patient 
or hospital related delays. Misdiagnosis of SAH occured in 12% of patients in a 
single-center study with 482 consecutive patients and misdiagnosis was associated 
with higher mortality and morbidity due to the increased risk of rebleeding, 
hydrocephalus and vasospasm (Kowalski et al., 2004). 
After the SAH diagnosis, the cause of bleeding should quickly be defined. DSA 
has been the golden standard but newer, non-invasive and fast imaging modalities 
(CTA and MRA) are used more and more to detect the bleeding site immediately.  
2.1.5.1 Catheter angiography with digital subtraction angiography technique 
Digital subtraction angiography (DSA) is a traditional imaging modality with a very 
high sensitivity and specificity to detect intracranial aneurysms. A complete four-
vessel angiography is performed to detect multiple aneurysms and 3D rotational 
angiography helps to detect small aneurysms and define the aneurysm configuration 
(van Rooij et al., 2008). If no aneurysm is found in four-vessel angiography, 
selective catheterization of both external carotid arteries is performed to exclude a 
dural arteriovenous fistula and/or DSA is repeated after a week to exclude a 
thrombosed aneurysm. 
DSA is an invasive diagnostic modality with an overall complication rate 
between 0.4 and 3%. Symptomatic complications occur in 0.4-0.5% of procedures 
(Willinsky et al., 2003; Ringer et al., 2008; Agid et al., 2010). Also, allergic 
reactions to contrast medium, renal failure and bleeding at the puncture site are 
possible complications. 
The advantage of DSA is that aneurysms detected in DSA can be directly treated 
using an endovascular coiling procedure during the same session and thus 
minimizing the risk of rebleeding in the hospital. DSA can also be used as a follow-
up modality after aneurysm treatment in both clipped and coiled aneurysms. It has 
the highest sensitivity to detect postoperative occlusion grades compared to other 
angiographic methods. However, because of its invasive nature, postoperative 
angiograms are nowadays often done with MRA in coiled aneurysms and 
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intraoperative with indocyanine green (ICG) fluorescence angiography, or on first 
postoperative day with CTA in clipped aneurysms (Raabe et al., 2005).  
2.1.5.2 Computed tomography (CT), CT angiography (CTA) and CT perfusion 
(CTP) 
CT is performed as soon as possible after SAH. Typically, the subarachnoid blood 
appears hyperdense on an unenhanced CT. The sensitivity of CT in SAH is 98-
100% in the first 12 hours after SAH, declining to 93% at 24 hours and to 57-85% 
after 6 days (van Gijn and van Dongen, 1982; Kassell et al., 1990b; Edlow, 2005). 
Blood in initial CT is graded with the Fisher grading system (Table 6) (Fisher et al., 
1980). The pattern of SAH in the first CT scan may suggest the location of the 
ruptured aneurysm (Karttunen et al., 2003). Intracerebral hematoma (ICH) occurs in 
20-30% of patients with aneurysmal rupture, but subdural hematomas are rare 
(about 2%) (van Gijn and van Dongen, 1982; Kassell and Torner, 1984; Kivisaari et 
al., 2001; van Gijn et al., 2007). Blood in ventricles is detected in 20-50% of initial 
CTs (Kassell and Torner, 1984; Le Roux and Winn, 1998). 
 
Table 6. Fisher grading system for initial CTs (Fisher et al., 1980). 
 
1 No subarachnoid blood  
2 A diffuse deposition or thin layers (<1mm) of blood 
3  Clots or thick layers (>1mm) of blood 
4 Subarachnoid hemorrhage of any thickness with intra-ventricular or intraparenchymal 
hemorrhage. 
 
CT is usually followed by CTA to detect aneurysms instantly. The sensitivity for 
detecting ruptured aneurysms is currently approximately 95% (92-98%) (Lenhart et 
al., 1997; White et al., 2000; Young et al., 2001; Kangasniemi et al., 2004; van Gijn 
et al., 2007; Zacharia et al., 2010). The sensitivity and specificity of CTA for 
aneurysm detection depends on aneurysm location and size, quality of images and 
experience of the radiologist (White et al., 2000; Kangasniemi et al., 2004). In the 
study of Dammert et al. (2004) comprising of 50 patients, the sensitivity was 100% 
for aneurysms larger than 12mm, 91% for aneurysms 5 to 12mm in size and 83% 
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for aneurysms smaller than 5mm. Disadvantages of CTA also include the need of 
iodinated contrast medium and artefacts from bone. CTA is better than DSA to 
define aneurysmal wall calcification and orientation of aneurysm with respect to 
intraparenchymal hemorrhage and bony structures and thus helping the 
neurosurgical planning (Bederson et al., 2009). 
CTA can be used to detect vasospasm after SAH with sensitivity rates as high as 
98% (Yoon et al., 2006; Binaghi et al., 2007). CTA can also be used to evaluate 
occlusion rates after surgical clipping with titanium clips, but it can not be used after 
endovascular treatment because of coil artefacts (Kahara, 2006). 
Computed tomography perfusion (CTP) is used in combination with CT and 
CTA to detect ischemic brain lesions caused by vasospasm after SAH (Harrigan et 
al., 2005). Perfusion images can be early predictors of secondary cerebral infarction 
in patients with vasospasm because these perfusion changes may occur up to three 
days before infarction can be detected on CT (Marshall et al., 2010). Perfusion 
images consist of different maps: mean transit time (MTT), time to peak (TTP), 
cerebral blood volume (CBV) and cerebral blood flow (CBF). Elevated MTT/TTP 
with normal CBF and normal or increased CBV indicates perfusion abnormality that 
is adequately compensated by autoregulation. Elevated MTT/TTP with reduced 
CBF and normal or increased CBV indicates perfusion abnormality with reversible 
cerebral ischemia (penumbra). Elevated MTT/TTP with reduced CBF and reduced 
CBV indicates perfusion abnormality with irreversible cerebral ischemia (Marshall 
et al., 2010).  
2.1.5.3 Lumbar puncture 
If CT is negative, lumbar puncture and amount of red blood cells in CSF is 
performed. Xantochromia is present 6 to 12 hours after SAH and thus lumbar 
puncture should be done more than 6 hours and preferably 12 hours after the 
headache onset to differentiate true SAH from a traumatic lumbar puncture (van 
Gijn et al., 2007). Bilirubin remains detectable until 2 to 3 weeks after bleeding (van 
Gijn et al., 2007; Zacharia et al., 2010).  
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2.1.5.4 Magnetic resonance imaging (MRI) and MR angiography (MRA) 
MRI is not usually used in emergency settings because the study time is long, it is 
sensitive to motion artefacts and not as widely available as CT (van Gijn and Rinkel, 
2001; Bederson et al., 2009). Furthermore, conventional MRI sequences are less 
sensitive to SAH than CT scanning (Mitchell et al., 2001; van Gijn and Rinkel, 
2001; Wiesmann et al., 2002). Blood in the subarachnoid space detected in MRI 
depends on sequences used as shown in Figure 1 (Noguchi et al., 1995; Mitchell et 
al., 2001; Rumboldt et al., 2003; Yuan et al., 2005). Fluid-attenuation inversion 
recovery (FLAIR) and T2* sequences are as sensitive as CT in the acute period (<4 
days from SAH) with a sensitivity rate 81-100% in FLAIR and 91-94% in T2* 
sequences, respectively (Mitchell et al., 2001; van Gijn and Rinkel, 2001; 
Wiesmann et al., 2002). The sensitivity of T2- weighted GRE images obtained in 
subacute period (4–30 days from hemorrhage) is 100% (Mitchell et al., 2001; Yuan 
et al., 2005). However, FLAIR sensitivity reduces in the subacute period, changing 
from 33% to 87% between studies (Mitchell et al., 2001; Yuan et al., 2005). MRI 
can be used if CT shows no blood, in subacute cases, or to detect other causes of 
SAH in patients with negative catheter angiograms (Yuan et al., 2005).  
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Figure 1. Histogram showing the sensitivities of the four MRI sequences and of CT in 
the acute and subacute periods adapted from Mitchell et al. (2001). 
 
MRI is much more sensitive than CT detecting parenchymal lesions after SAH in 
the late phase (Awad et al., 1986; Kivisaari et al., 2001). Parenchymal lesions 
detected on late MRIs can be caused by a bleed itself (superficial hemosiderin, 
residual sign of hematoma), by vasospasm or by a treatment complication. The 
etiology of lesions can be determined on the basis of vascular anatomy when 
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comparing primary CTs with late MRIs and knowing the clinical data of each 
patient (Hadjivassiliou et al., 2001; Kivisaari et al., 2001). Thus, ischemic lesions in 
parental artery territory (vascular territory of the ruptured aneurysm) and other 
vascular territories (caused by vasospasm) can thus be differentiated. Parental artery 
infarctions can be related to the primary bleeding or complications of treatment, 
such as vessel rupture, dissection or thromboembolism (Rabinstein et al., 2005). 
Surgical treatment when inadvertently using brain retractors may cause injuries to 
frontotemporal lobes and those do not follow the vascular anatomy of the brain 
(Kivisaari et al., 2001). Therefore, avoiding usage of retractors is important 
whenever possible. 
Magnetic resonance angiography (MRA) is used to detect unruptured intracranial 
aneurysms. It does not require iodinated contrast or ionizing radiation and is thus 
safer for screening than CTA or DSA (Bederson et al., 2009). Sensitivity of three-
dimensional time-of-flight (TOF) MRA for cerebral aneurysms is between 55% and 
93% (White et al., 2000; Bederson et al., 2009). Sensitivity depends on the size of 
the aneurysm: aneurysms more than 3mm have a sensitivity of around 94%, whereas 
sensitivity for aneurysms less than 3mm is as low as 38% (White et al., 2000; 
Zacharia et al., 2010).  
MRA can also be used to follow-up previously coiled aneurysms; the sensitivity 
to detect a residual aneurysm is approximately 90% (Kahara et al., 1999; Kwee and 
Kwee, 2007; Urbach et al., 2008). Both TOF-MRA and contrast-enhanced MRA 
(CE-MRA) are good follow-up sequences after coiling (Kahara et al., 1999; Gauvrit 
et al., 2006; Anzalone et al., 2008) and majority of aneurysms can be followed up 
solely with TOF-MRA (Kahara, 2006). Sensitivity and specificity of CE-MRA in 
detection of residual flow are 87-93% and 92-96%, respectively (Gauvrit et al., 
2006; Kwee and Kwee, 2007; Lubicz et al., 2008). Follow-up of clipped aneurysms 
is not possible due to artefacts.  
2.1.6 Complications of SAH 
High mortality and morbidity of SAH is not only connected to the initial bleeding 
but also to many complications, the most common are listed in Table 7. Aneurysmal 
rupture may lead to a prolonged period of global cerebral ischemia at the time of 
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bleeding, probably as a result of increased intracranial pressure to a level of arteries. 
Outcome is generally fatal due to progressive dysfunction of the brainstem. Because 
of high mortality of recurrent SAH, early treatment is nowadays preferred in most 
centres (Ohman and Heiskanen, 1989; Bederson et al., 2009). Tranexamic acid is 
used in many centers to prevent ultra-early rebleedings (Hillman et al., 2002). 
Vasospasm and hydrocephalus are discussed below, and rebleeding in Chapter 
2.1.10.  
 
Table 7. Common complications of aneurysmal subarachnoid hemorrhage 
(Wartenberg and Mayer, 2010). 
 
Immediate cerebral ischemia 
Rebleeding  
Vasospasm 
Delayed cerebral ischemia 
Hydrocephalus 
Seizures 
Cardiopulmonary dysfunction: hypo/hypertension, pneumonia, pulmonary edema 
Electronic disturbances: hypo/hypernatremia, hypomagnesemia 
Fever  
Anemia  
Hyperglycemia 
2.1.6.1 Vasospasm 
Cerebral vasospasm is the delayed narrowing of cerebral arteries after SAH, which 
is often associated with diminished perfusion in the distal territory of the affected 
artery. A typical onset for vasospasm is three to five days after the hemorrhage, 
maximal narrowing at five to 14 days, and a gradual resolution over two to four 
weeks (Fisher et al., 1977; Bederson et al., 2009). Vasospasm affects 60 to 70% of 
patients after SAH, resulting in symptomatic delayed ischemia in approximately 20-
35% of SAH patients (Raymond and Roy, 1997; Debrun et al., 1998; Koebbe et al., 
2006). Half of these patients have disability or death resulting from clinical 
vasospasm (Raymond and Roy, 1997; Debrun et al., 1998). With early surgery and 
optimal medical management the morbidity and mortality rate from vasospasm has 
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decreased to approximately 4 to 12% (Ohman and Heiskanen, 1988; Ohman and 
Heiskanen, 1989; Ohman et al., 1991a; Raymond and Roy, 1997).  
For patients over 60 years, higher Fisher grade on initial CT scan and higher 
H&H on admission are important predictors for the development of vasospasm 
(Schievink et al., 2000; Feigin et al., 2005; Harrod et al., 2005; van Gijn et al., 
2007). Hypertension is also a risk factor for developing clinical vasospasm (Ohman 
et al., 1991b). There does not seem to be a difference between surgical clipping and 
endovascular coiling regarding the risk of vasospasm (de Oliveira et al., 2007a). 
Vasospasm can be treated by controlling intracranial pressure, decreasing brain 
oxygen use, and improving CBF. Triple-H therapy is a traditional treatment method 
for vasospasm with hypervolemia, hypertension and hemodilution, but there is no 
good evidence for a positive effect (Bederson et al., 2009). Hypertension is more 
effective in increasing cerebral blood flow than hemodilution or hypervolemia 
(Dankbaar et al., 2010). Altogether, strict avoidance of hypovolemia, hypotension, 
hyponatremia, hyperglycemia and hyperthermia are important in preventing delayed 
cerebral ischemia in SAH patients (Diringer, 2009).  
Calcium channel blocker nimodipine reduces the risk of secondary ischemia and 
poor outcome (Ohman and Heiskanen, 1988; Ohman et al., 1991a; Zacharia et al., 
2010). Hypomagnesemia appears to be common after SAH and has been associated 
with both poor outcome and vasospasm. Intravenous magnesium infusion seems to 
reduce delayed cerebral ischemia but did not improve the clinical outcome in a 
recent large, randomized placebo-controlled trial (van den Bergh et al., 2005; 
Dorhout Mees et al., 2012). 
Endovascular transluminal angioplasty or intra-arterial infusion of vasodilators 
can be used to treat vasospasm. Transluminal balloon angioplasty can be used in 
large, proximal vessels and it is effective. However, major complications like vessel 
rupture, occlusion, dissection, hemorrhagic infarction and hemorrhage from 
untreated aneurysms occur in approximately 5% of procedures (Diringer, 2009). 
2.1.6.2 Hydrocephalus 
Hydrocephalus is detected in up to 30% of SAH patients (Mehta et al., 1996; 
Findlay and Deagle, 1998; Sheehan et al., 1999; Franz et al., 2001). Acute 
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hydrocephalus develops between 24 hours and three days after the hemorrhage, 
subacute hydrocephalus four to 13 days after SAH, and chronic hydrocephalus 
develops more than two weeks after the bleeding (Vale et al., 1997; Jartti et al., 
2004; Jartti et al., 2008). The incidence of acute hydrocephalus after SAH is 
between 15 and 30% (Mehta et al., 1996; Findlay and Deagle, 1998; Sheehan et al., 
1999; Franz et al., 2001). Slow pupillary responses to light, deviation of the eyes 
and loss of consciousness are characteristic for acute hydrocephalus. Poor-grade 
patients and patients with high Fisher grade on initial CT, intraventicular 
hemorrhage and posterior circulation aneurysms have a high risk developing 
hydrocephalus (Graff-Radford et al., 1989; Vermeij et al., 1994; Mehta et al., 1996; 
Sheehan et al., 1999). Less than half of the patients with acute hydrocephalus will 
require external ventricular drainage (Mehta et al. 1996, Sethi et al. 2000). 
Ventriculostomy is an effective procedure for management of acute hydrocephalus, 
but it has been connected to an increased rebleeding rate (Pare et al., 1992). 
However, more recent data suggests that ventriculostomy followed by early 
treatment of the ruptured aneurysm does not increase the risk of rebleeding (Mehta 
et al., 1996; McIver et al., 2002). Drainage of CSF can also be achieved by opening 
the basal cisterns, fenestration of the lamina terminalis or third ventriculostomy 
through the fenestrated lamina terminalis during the aneurysm surgery (Lehto H et 
al., 2009).  
Subacute hydrocephalus is detected in only 2-3% of SAH patients (Mehta et al., 
1996; Sethi et al., 2000). Chronic hydrocephalus with gait disturbance, impaired 
intellectual function or progressive lethargy is observed in about 20% of patients 
after SAH (Tapaninaho et al., 1993; Sheehan et al., 1999; Sethi et al., 2000; 
Widenka et al., 2000; Kim et al., 2006; Varelas et al., 2006; de Oliveira et al., 
2007b; Jartti et al., 2008). Development of chronic hydrocephalus correlates with 
clinical grade on admission, Fisher grade, acute hydrocephalus and intraventricular 
hemorrhage (Tapaninaho et al., 1993; Vermeij et al., 1994; Vale et al., 1997; 
Sheehan et al., 1999; Widenka et al., 2000; Yoshioka et al., 2000). Patients with 
ruptured vertebrobasilar area aneurysms have more (28%) chronic hydrocephalus 
than patients with aneurysms in ACoA (14%) or MCA (4%) (Tapaninaho et al., 
1993; Yoshioka et al., 2000).  
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2.1.6.3 Other complications 
Electrocardiographic changes, elevated cardiac enzymes and arrhythmias are 
common in the first two days after SAH. However, those are typically benign 
(Diringer, 2009). Hyponatremia after SAH ranges from 10 to 30%, being more 
common in poor-grade patients, patients with ACoA aneurysms and hydrocephalus 
(Bederson et al., 2009; Diringer, 2009). Hyponatremia may be an independent risk 
factor for poor outcomes (Bederson et al., 2009; Diringer, 2009). Seizures are 
common after SAH with up to 14% of SAH patients suffering from secondary 
epilepsy (Kassell et al., 1990b). 
2.1.7 Management 
The goal of aneurysm treatment is to prevent rebleeding, which is associated with 
high mortality (Hijdra et al., 1987). Rebleeding is prevented by eliminating the 
aneurysm from the circulation while preserving blood flow in the parental artery and 
perforating arteries. The aneurysm can be treated either with microsurgical or 
endovascular techniques. Parent artery occlusion is an option for aneurysms not 
suitable for clipping or coiling, and for peripheral aneurysms if collaterals allow. 
Some aneurysms are best treated with multimodality approaches using both 
techniques (hybrid treatment) (Pearl et al., 2010). Early treatment is widely used to 
prevent in-hospital rebleeding (Ohman and Heiskanen, 1989; Kassell et al., 1990a).  
Treatment of unruptured aneurysms is debated a lot because a large international 
study of unruptured intracranial aneurysms, ISUIA, showed that rupture risk in 
small aneurysms (<7mm) is very low, especially in patients with no previous SAH 
(Wiebers et al., 2003; Mitchell et al., 2004). In 2000, an expert panel of the 
American Heart Association recommended that aneurysms in patients with long life 
expectancy, previous SAH, a family history of aneurysm rupture, large aneurysms 
(≥10mm), symptomatic aneurysms or observed aneurysm growth, should be treated 
(Bederson et al., 2000). However, risk of aneurysm rupture is higher in Finnish and 
Japanese populations compared to other industrialized countries, and most ruptured 
aneurysms are less than 10mm so treatment is recommended to be more aggressive 
in Finland (Sarti et al., 1991; Broderick et al., 1994; Ostbye et al., 1997; Rinkel et 
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al., 1998; Cesarini et al., 1999; Ingall et al., 2000; Forget et al., 2001; Inagawa, 
2001; Juvela 2001; Pobereskin, 2001; de Rooij et al., 2007; Koffijberg et al., 2008).   
2.1.7.1 Microsurgical clipping 
Aneurysms can be isolated from the circulation with microsurgical clipping. In rare 
cases aneurysms are treated by trapping, wrapping or proximal vessel occlusion 
with or without extracranial-intracranial bypass (Andaluz and Zuccarello, 2011). 
The operation is performed under a high magnification microscope, preferably with 
intraoperative ICG angiography and advanced neuroanesthesiolgy (Hernesniemi et 
al., 2005b; Raabe et al., 2005; Randell et al., 2006). CSF drainage can be achieved 
during surgery by opening the basal cisterns, fenestration of the lamina terminalis or 
catheterization of the third ventricle through fenestrated lamina terminalis to reduce 
intracranial pressure (Lehto et al., 2009). Anterior circulation aneurysms can be 
clipped by using the pterional approach, the lateral supraorbital approach, the 
orbitozygomatic approach or the interhemispheric approach (Hernesniemi et al., 
2005a). Posterior circulation aneurysms are clipped by pterional, subtemporal, 
lateral suboccipital or anterior petrosectomy approaches. 
 Postoperative complete occlusion grade has been found in 74-88% and 
incomplete occlusion has been found in 3-6% of aneurysms, respectively (Vanninen 
et al., 1999; Thornton et al., 2000; Kivisaari et al., 2004; Molyneux et al., 2005). 
Nowadays, intraoperative ICG videoangiography is widely used to documentate clip 
positioning and aneurysm occlusion and to detect the patency of adjacent arteries 
(Raabe et al., 2005). Posterior circulation aneurysms and large aneurysms often 
have more incomplete occlusions of the aneurysms and higher morbidity and 
mortality after surgery than anterior circulation aneurysms (Schievink et al., 1995c; 
Kivisaari et al., 2004). Overall, the complication rate has been as high as 30% with 
permanent morbidity 4-10% and mortality of 2-4% (Raaymakers et al., 1998; 
Vanninen et al., 1999; Johnston et al., 2000). Major vessel occlusion was detected in 
6% of clipped, ruptured aneurysms in a Finnish study with 493 consecutive patients 
(Kivisaari et al., 2004).  
The randomized International Subarachnoid Aneurysm Trial (ISAT) comprising 
of 2143 SAH patients found rebleeding risk after surgery to be 1.2% in a four year 
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mean follow-up time (Molyneux et al., 2005). Cumulative risk of recurrent 
aneurysmal bleeding has been as high as 3.2% at 10 years and 9.0% at 20 years after 
the surgical treatment, counting both de novo bleedings and bleedings from a 
residual aneurysm (Tsutsumi et al., 1998; Wermer et al., 2005). Risk of recurrence 
of a completely clipped aneurysm is 0.3-0.9% per patient-year (Tsutsumi et al., 
2001; Fulkerson et al., 2009). 
Surgery-related death in patients with unruptured intracranial aneurysms is 1-3% 
and morbidity 10-30% with permanent disability approximately 3% (Raaymakers et 
al., 1998; Johnston et al., 2000; Pierot et al., 2008a). 
2.1.7.2 Endovascular treatment 
Guglielmi detachable coils (GDC) were introduced in 1991 by Guglielmi et al. 
(1991). Platinum coils are placed into the aneurysm through a microcatheter and 
detached from a stainless steel microguidewire by electric current. The aneurysm is 
packed with several coils. The coils induce thrombosis, thereby excluding the 
aneurysm from the circulation. Traditionally, coiling is considered feasible if the 
neck of the aneurysm is not wide (a dome-neck ratio is more than 1.5) and 
perforating branches do not arise from the aneurysm. Coils have been developed 
further (2D-coils, 3D-coils, soft coils, ultrasoft coils, biologically active coils, 
hydrogel coils etc.) to enable better aneurysm filling and to decrease the 
recanalization rate (Pearl et al., 2010). Matrix-type coils are modified GDCs with 
polyglycolic-polylactic acid polymer coating and HydroCoils are platinum coils 
coated with an expanding polymer that reacts to blood (Niimi et al., 2006; Ishii et 
al., 2008; Pierot et al., 2008b; Marjamaa et al., 2009). However, the benefit 
compared to GDCs is not proved (Niimi et al., 2006; Ishii et al., 2008; Pierot et al., 
2008b). Balloon remodelling techniques and stent-assisted coiling also made coiling 
of wide neck aneurysms possible. The balloon is temporary inflated across the 
aneurysm neck during embolization to avoid coil migration into the parent artery. 
Stent-assisted coiling can be used to treat large, fusiform or wide-necked aneurysms 
(Tahtinen et al., 2009). New generation flow-diverter stents may induce thrombosis 
in the aneurysm sac by reducing flow even without subsequent coiling of the 
aneurysm (Nelson et al., 2011; Tahtinen et al., 2012). The disadvantage of stents is 
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the need for antiaggregative medication because of the risk of stent thrombosis 
(Pearl et al., 2010). 
Complications related to endovascular coiling are aneurysm rupture, 
tromboembolic events and arterial dissection. Complication rate is approximately 
10% (8-21%) but symptomatic complications occur in 5% (1-9%) of patients, and 
3% are permanent (Table 8) (Casasco et al., 1993; Raymond and Roy, 1997; 
Vinuela et al., 1997; Kuether et al., 1998; Brilstra et al., 1999; Vanninen et al., 1999; 
Roy et al., 2001; Ng et al., 2002; Friedman et al., 2003; Murayama et al., 2003; 
Willinsky et al., 2003; Niimi et al., 2006; Pouratian et al., 2006; Ishii et al., 2008; 
Peluso et al., 2008; Pierot et al., 2008b; van Rooij et al., 2009). Mortality related to 
endovascular treatment is around 1% (0.5-2%) (Johnston et al., 1998; Lanterna et 
al., 2004; Niimi et al., 2006; Pierot et al., 2008a; van Rooij et al., 2009).  
Perforation of the aneurysm sac occurs in 2-3% of patients during aneurysm 
coiling and the rate is higher in small and ruptured aneurysms (Vinuela et al., 1997; 
Debrun et al., 1998; Sluzewski et al., 2001; Murayama et al., 2003; Wiebers et al., 
2003; van Rooij et al., 2009). Thromboembolic complications are the most common 
type of complication in the endovascular treatment of intracranial aneurysms and are 
affected by aneurysm size (van Rooij et al., 2009). The deficits were noticed during 
or immediately after the procedure in 59% of cases, while 41% occurred 12-48 
hours after treatment (Pelz et al., 1998). Heparinization is used to minimize 
thromboembolic complications. Activated clotting time (ACT) should be 250-300 
seconds during the intervention. Aspirin is used routinely in some centres after 
endovascular coiling.   
Morbidity and mortality rates among patients with unruptured aneurysms are 
comparable to that of the endovascular treatment of ruptured aneurysms (Standhardt 
et al., 2008). The case-fatality rate in unruptured aneurysm embolization is 0.6% 
and the permanent morbidity rate is between 4-7% (Brilstra et al., 1999; Roy et al., 
2001; Lanterna et al., 2004). Morbidity has decreased from the years when 
endovascular coiling began (Debrun et al., 1998; Johnston et al., 1998; Roy et al., 
2001; Ng et al., 2002; Lanterna et al., 2004; Pouratian et al., 2006; Pierot et al., 
2008a).   
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Table 8. Overview of mortality and permanent morbidity rates in coiled aneurysms. 
 
Series No of 
patients 
No of 
aneurysms 
Ruptured/ 
Unruptured 
Procedure-
related 
mortality 
(%) 
Permanent 
morbidity 
rate (%) 
Johnston et 
al., 2000 
 62 U 1.6 8 
Murayama et 
al., 1999 
115 120 U 0 4.3 
Brilstra et al., 
1999 
 1256 R+U  3.7 
Roy et al., 
2001 
116 125 U 0 5.2 
Goddard et 
al., 2002 
62 73 U 0 0 
Ng et al., 
2002 
81 81 R 2.5 2.5 
Ng et al., 
2002 
63 79 U 0 0 
Vinuela et al., 
1997 
403 403 R 1.7  
Niimi et al., 
2006 
70 74 R+U 1.4 1.4 
van Rooij et 
al., 2009 
187 196 R+U 1.1 2.1 
Lanterna et 
al., 2004 
1379  U 0.6 7 
Willinsky et 
al., 2009 
377 391 R 1.6 1.3 
Pierot et al., 
2008b 
127  R 1.4 3.6 
Pierot et al., 
2008b 
98  U 0 1.0 
Pierot et al., 
2008a 
 739 U 1.7 1.4 
R=Ruptured aneurysm; U=Unruptured aneurysm 
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2.1.7.3 Retreatment 
Retreatment is needed more often after endovascular coiling than after surgical 
clipping (Campi et al., 2007; van Rooij et al., 2009). Risk factors for retreatment are 
aneurysm size >10mm, neck width >4mm and initial incomplete aneurysm 
occlusion (Ries et al., 2007; van Rooij et al., 2009). Retreatment rate is about 10% 
(range 5-21%) (Kuether et al., 1998; Ng et al., 2002; Niimi et al., 2006; Ries et al., 
2007; van Rooij et al., 2009; Willinsky et al., 2009). Complication rate after 
retreatment differs between studies with no mortality or permanent morbidity in 
some studies (Slob et al., 2004; Ries et al., 2007). However, in other studies severe 
morbidity and mortality have been between 3 and 11% (Park et al., 2005; Carat 
Investigators, 2006; Henkes et al., 2006). Additional microsurgical treatment after 
incomplete coiling is challenging and has a high morbidity rate (Romani et al., 
2011).  
2.1.8 Outcome 
2.1.8.1 Clinical outcome 
Glasgow Outcome Scale (GOS, Table 9) and modified Rankin scale (mRS, Table 
10) are commonly used for outcome assessment following SAH.  
 
 
Table 9. Glasgow Outcome Scale (GOS) (Jennett and Bond, 1975). 
  
1  Death 
2  Persistent vegetative state 
3  Severe disability: conscious, but totally dependent on others 
4  Moderate disability: neurological deficit or intellectual impairment, but independent life 
5  Good recovery: full and independent life, no or minimal neurological deficit 
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Table 10. Modified Rankin Scale (mRS) (Farrell et al., 1991). 
 
0  No symptoms at all 
1  No significant disability despite symptoms; able to carry out all usual duties and 
activities 
2  Slight disability; unable to carry out all previous activities, but able to look after own 
affairs without assistance 
3  Moderate disability; requiring some help, but able to walk without assistance 
4  Moderately severe disability; unable to walk without assistance and unable to attend to 
own bodily needs without assistance 
5  Severe disability; bedridden, incontinent and requiring constant nursing care and 
attention  
6 Death 
 
 
Rupture of intracranial aneurysm is associated with 24-77% mortality and 15-30% 
morbidity (Ingall et al., 1989; Sarti et al., 1991; Broderick et al., 1994; Hop et al., 
1997; Inagawa, 1997; Inagawa, 2001; Pobereskin, 2001; Stegmayr et al., 2004; 
Inagawa, 2005; Pajunen et al., 2005). About 12% (3-17%) of all SAH patients die 
without reaching medical attention (Broderick et al., 1994; Fogelholm et al., 1995; 
Schievink et al., 1995a; Schievink et al., 1995b; Truelsen et al., 1998) and 25-37% 
die within 24 hours after bleeding (Hop et al., 1997; Stegmayr et al., 2004). Overall 
case fatality rate is  27- 43% in the first week, 33-61% at one month, and 33-77% at 
one year (Ingall et al., 1989; Sarti et al., 1991; Broderick et al., 1994; Hop et al., 
1997; Inagawa, 1997; Inagawa, 2001; Pobereskin, 2001; Stegmayr et al., 2004; 
Inagawa, 2005; Pajunen et al., 2005). Mortality has slightly decreased over the 
decades with previous death rates around 50% when compared to the less than 24% 
in more recent studies (Ingall et al., 1989; Sarti et al., 1991; Broderick et al., 1994; 
Ostbye et al., 1997; Truelsen et al., 1998; Cesarini et al., 1999; Inagawa, 2001; 
Stegmayr et al., 2004; Qureshi et al., 2005; Koffijberg et al., 2008; Molyneux et al., 
2009). The direct causes of death and major morbidity according to Kassell et al. 
(1990a) are: cerebral infarction due to vasospasm (34%), direct effect of hemorrhage 
(26%), rebleeding before treatment (17%), treatment complications (11%), 
intracerebral hematoma (5%), and hydrocephalus (3%). Patients with sudden death 
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have more posterior circulation aneurysms, IVH and acute pulmonary edema than 
patients who reach hospital (Schievink et al., 1995b). Patient age, poor clinical 
grade on admission and high Fisher grade on initial CT scan are directly associated 
with 30-day mortality (Kassell et al., 1990b; Saveland et al., 1993; Inagawa, 2001; 
Claassen et al., 2002; Mocco et al., 2006; Koffijberg et al., 2008). Also, aneurysm 
size >13mm, aneurysm rebleeding, clipping as treatment modality and delayed 
cerebral ischemia from vasospasm are predisposing factors to poor outcomes in 
some studies (Kassell et al., 1990b; Broderick et al., 1994; Shimoda et al., 2001; 
Claassen et al., 2002; Yamada et al., 2003; Mocco et al., 2006; Wartenberg et al., 
2006).  
   Favorable outcomes are detected in approximately 62% (40-87%) of SAH 
patients (Table 11). However, even the 59-80% of patients with good outcomes 
have a reduced quality of life after SAH (Hutter and Gilsbach, 1993; Ogden et al., 
1993; Hop et al., 1997). Cognitive impairment occurs in approximately one third of 
patients with favourable outcomes (Scott et al., 2010). Verbal and visual memory 
are frequently (14-61%) impaired in these patients (Hackett and Anderson, 2000; 
Al-Khindi et al., 2010; Scott et al., 2010). However, cognitive deficits improve 
slowly within a few years after SAH (Hutter and Gilsbach, 1993; Ogden et al., 1993; 
Hop et al., 1997). Even 40-94% of patients with good outcomes are unable to return 
to their previous occupation (Ogden et al., 1993; Hackett and Anderson, 2000; Al-
Khindi et al., 2010). Some patients return to work with less responsibility or as part-
time workers because of depression, fatigue and cognitive problems (Al-Khindi et 
al., 2010).  
Patients with anterior circulation aneurysms and surgically treated aneurysms 
have slightly more cognitive deficits than patients with posterior circulation 
aneurysms or coiled aneurysms (Hadjivassiliou et al., 2001; Bendel et al., 2008; 
Scott et al., 2010). SAH patients with good outcomes at one year after the bleeding 
have higher long-term mortality rates than the general population, mainly due to 
cerebrovascular and cardiovascular deaths and cancer (Ronkainen et al., 2001; 
Lehecka et al., 2007; Molyneux et al., 2009; Huttunen et al., 2011). 
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The outcome after treatment of unruptured aneurysms is not as widely 
studied as the outcome after SAH. The short-term outcome is good in spite of 
remarkable morbidity and mortality related to aneurysm treatment. In recent studies, 
94-100% of patients were asymptomatic at the time of discharge (Ng et al., 2002; 
Pierot et al., 2008a). Most long-term outcome studies of patients with unruptured 
aneurysms include patients with previous SAH and thus the outcome can be related 
to SAH, not truly to unruptured aneurysms (Juvela et al., 1993; Juvela et al., 2000). 
Long-term survival among patients with unruptured aneurysms has been studied in 
only one study (Britz et al., 2004). It showed that survival among SAH patients was 
significantly lower than among patients with unruptured aneurysms, but after the 
first-year post clipping, differences in the survival rate diminished (Britz et al., 
2004). They compared ruptured with unruptured aneurysms and untreated with 
clipped aneurysms. The study showed that patients with untreated unruptured 
aneurysms were 30% more likely to die than patients in the clipped group, and 
untreated patients were more likely to die from neurologically related causes (5.6%) 
than patients with clipped aneurysms (2.3%) (Britz et al., 2004).   
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Table 11. Summary of largest long-term clinical outcome studies. The H&H and GOS figures represent percentages of patients. 
Series Number 
of  
patients 
Ruptured/ 
Unruptured 
Treatment 
method 
Mean 
age 
Good-
grade 
(H&H 1-2) 
Poor-grade 
(H&H 4-5) 
Follow-
up 
months 
Dead 
(GOS 1) 
Disability 
(GOS 2-3) 
Favourable 
outcome 
(GOS  4-5)  
Kremer et al., 2002 79 R coiling 51 67 33 41 29 11 60 
Molyneux et al., 2005 1063 R coiling  88 5 12 8 16 76 
Molyneux et al., 2009 857 R clipping 52 88 10 60 17 15 68 
Molyneux et al., 2009 867 R coiling 52 85 11 60 13 15 72 
Mocco et al., 2006 98 R coiling+clipping 55 0 100 12 43 18 39 
Ng et al., 2002 73 R coiling 52 65 13 2 26 5 70 
Pierot et al., 2008b 127 R coiling 49 79 21 12 11 2 87 
Pierot et al., 2008b 98 U coiling 49 100 0 12 0 1 99 
Willinsky et al., 2009 377 R coiling 55 62 15 22 9 18 74 
Wartenberg et al.,2006 576 R coiling+clipping 53 42 27 3 21 17 62 
Koivisto et al., 2000 57 R clipping 50 63 12 12 16 9 75 
Koivisto et al., 2000 52 R coiling 49 60 17 12 13 8 79 
GOS= Glasgow outcome scale; H&H=Hunt and Hess scale; R=Ruptured aneurysm; U=Unruptured aneurysm
4
0
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 2.1.8.2 Angiographic occlusion grade after aneurysm treatment 
Occlusion grade is subjectively estimated and thus reported occlusion grades vary a 
lot. Two most often used methods to assess occlusion grade are: Raymond 
classification scale (Raymond et al., 1997) and a quantitative classification system, 
Figure 2 (Raymond et al., 2003). Occlusion grade is complete (100%) if there is no 
contrast filling in the aneurysm. Aneurysm has a neck remnant (90-100%) if there is 
small contrast filling in the neck of the aneurysm. Residual aneurysm (<90%) shows 
contrast filling in the body of the aneurysm. The results in angiographic follow-up 
examinations can be classified as stable (no increase in contrast filling in the 
aneurysm), further thrombosis (i.e. progression, decrease in contrast filling), and 
recanalization (any increase in contrast filling, with or without coil compaction).  
 
 
 
 
 
100%    90-100%  <90% 
 
Figure 2. Modified Raymond classification with three different categories. In original 
scale neck remnant is divided into dog ear and neck remnant (Raymond et al., 1997). 
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Initial complete obliteration has previously been reported in approximately 54% 
(26-88%) of ruptured aneurysms, neck remnant in 34% (18-50%) and incomplete 
occlusion in 12% (2-26%) of ruptured aneurysms (Raymond and Roy, 1997; 
Kuether et al., 1998; Byrne et al., 1999; Cognard et al., 1999; Murayama et al., 
1999; Solander et al., 1999; Vanninen et al., 1999; Koivisto et al., 2000; Molyneux 
et al., 2005; Rabinstein et al., 2005; Ferns et al., 2009). Complete occlusion has been 
directly associated with small aneurysm size and dome-neck ratio more than 1.5 
(Casasco et al., 1993; Debrun et al., 1998; Ng et al., 2002).  
Clipped aneurysms have a better primary occlusion grade than endovascularly 
treated aneurysms. In a review by Thornton et al. (2000), incomplete aneurysm 
occlusion was seen in approximately 5% of clipped aneurysms. In a Finnish study 
(Kivisaari et al., 2004), surgically treated aneurysms had a complete obliteration rate 
in 88% of aneurysms (86% in ruptured, 91% in unruptured), 9% had neck remnant 
and 3% were incompletely clipped. Surgically treated aneurysms are thought to be 
stable after treatment and no long-term follow-up is routinely used. However, 3% of 
clipped aneurysms had recanalization in angiogram performed approximately nine 
years after the operation (Tsutsumi et al., 2001) and the annual regrowth rate is 0.3-
0.5% for completely clipped aneurysms (Juvela et al., 1993; David et al., 1999; 
Tsutsumi et al., 2001). 
Endovascularly treated aneurysms, however, need long-term angiographic 
follow-up because recanalization occurs more often (Hayakawa et al., 2000; 
Koivisto et al., 2000; Thornton et al., 2002; Raymond et al., 2003). Recanalization 
rate is approximately 25% (15-57%) (Byrne et al., 1999; Ng et al., 2002; Murayama 
et al., 2003; Niimi et al., 2006; Piotin et al., 2007; Ishii et al., 2008; Willinsky et al., 
2009) and at least three years follow-up is required (Ng et al., 2002). 
 Mid-term follow-up studies have demonstrated that aneurysm growth appears in 
up to 49% of coiled aneurysms when complete occlusion is not achieved primarily 
or angiographic stability is not achieved during the 12 -month follow-up (Hayakawa 
et al., 2000). However, a stable morphological result, with or without a remnant, 
during a 12-month interval predict a low (4.8%) recanalization risk (Holmin et al., 
2008; Sprengers et al., 2008). Other risk factors for reopening are large aneurysm 
size (>10mm), packing ratio less than 50% and initial presence of intraluminal 
thrombus (Casasco et al., 1993; Kuether et al., 1998; Solander et al., 1999; 
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Hayakawa et al., 2000; Raymond et al., 2003; Kai et al., 2005; Sprengers et al., 
2008; Standhardt et al., 2008; Willinsky et al., 2009). Ruptured aneurysms have a 
higher recanalization rate than unruptured aneurysms (Cognard et al., 1999; Piotin et 
al., 2007).  
Long-term (>5 years) follow-up studies with most patients included are still 
limited (Table 12). In a study by Holmin et al. (2008) long-term follow-up results in 
ruptured aneurysms were as follows: 62% (197/320) were completely occluded, 
30% (97/320) had a neck remnant, and 8% (26/320) were incompletely occluded. 
Aneurysms that were stable during a 12-month interval had a low risk of 
morphological deterioration. In conclusion, adequately coiled aneurysms are 
thought to be stable and the rebleeding rate low (Holmin et al., 2008; Sprengers et 
al., 2008; Schaafsma et al., 2009).  
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Table 12. Recanalization rates in studies with follow-up time of one year or more. 
Series Number 
of 
patients  
(aneurys
ms) 
Ruptured/ 
Unruptured 
Initial 
occlusion 
grade 
 
Follow-up 
months (range) 
Follow-up 
occlusion 
grade 
Progression Stable 
occlusion 
Recanalization 
   
C
o
m
p
le
te
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k
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n
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n
t 
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m
p
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te
 
 
C
o
m
p
le
te
 
N
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k
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n
a
n
t 
In
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m
p
le
te
 
   
Molyneux et al., 2005 881 R - - - 12 66 26 8 - - - 
Pierot et al., 2008b 165 (171) R+U 44 26 29 12 - - - 31 43 26 
Pierot et al., 2008a (739) U 59 22 19 - - - - - - - 
Raymond et al., 2003 466 (501) R+U 36 46 14 12 38 46 15 - - 34 
Niimi et al., 2006 70 (74) R+U 18 41 42 12 (0-34) - - - 17 55 28 
Piotin et al., 2007 223 (255) R+U 65 19 16 12 (3-43) - - - - - 29 
Koivisto et al., 2000 52 R 55 38 6 12 77 19 4 - - - 
Gauvrit et al., 2006  106 (107) R+U 83 15 2 13 (5-27) 61 20 20 - - 31 
Urbach et al., 2008 50 (58) R 90 4 4 14  78 2 18 - - - 
4
4
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Hayakawa et al., 2000 71 (73) R+U 0 100 0 17 - - - 25 26 49 
Thornton et al., 2002 130 (141) R+U 39 46 15 17 (6-62) 61 22 17 46 *) 26 *) 28*) 
Kole et al., 2005 160 (163) R+U 16 57 27 18 (1-76) 19 - - 9 - - 
Willinsky et al., 2009 377 (391) R 43 36 20 22 - - - 22 59 19 
Ng et al., 2002 144 (160) R+U 46 16 38 24 - - - - - 33 
Mejdoubi et al., 2006 222 (234) R 81 11 8 26 (0-69) 73 21 5 7 75 18 
Ries et al., 2007 323 (342) R+U 70 20 11 29 (6-132) - - - - - 21 
Roy et al., 2001 116 (125) U 50 45 5 32 (1-81) 49 38 14 - - - 
Standhardt et al., 2008 173 (202) U 58 34 9 35 48 24 28 - - - 
Sprengers et al., 2008 104 (111) R+U 100     - - 72 (60-120) 96 3 1 0 96 4 
R=Ruptured aneurysm; U=Unruptured aneurysm 
*)of incomplete aneurysms 
4
5
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2.1.8.3 Long-term MRI findings 
Patients with surgically treated aneurysms have a higher infarction rate than patients 
with coiled aneurysms (Koivisto et al., 2000; Hadjivassiliou et al., 2001; Kivisaari et 
al., 2001; Bendel et al., 2008). Infarction rate after aneurysmal SAH is as high as 
79-89% in clipped patients compared to 57% in endovascularly treated patients 
(Koivisto et al., 2000; Hadjivassiliou et al., 2001; Kivisaari et al., 2001; Bendel et 
al., 2008). Infarction in the vascular territory of the ruptured aneurysm was detected 
in 21% of endovascular and 46% of the surgical patients (Koivisto et al., 2000; 
Bendel et al., 2008). Although lesions consistent with infarction seen in CT or MRI 
sometimes appear extensive, patients may in fact be asymptomatic and patients with 
deep infarctions are more often asymptomatic than those with cortical lesions 
(Rabinstein et al., 2005). Ischemic lesions seen in MRIs correlate with 
neuropsychological deficits (Bendel et al., 2008; Al-Khindi et al., 2010). 
2.1.9 Follow-up strategy 
2.1.9.1 De novo aneurysm formation 
De novo aneurysms are new aneurysms that have not been verified in previous 
angiographies. The annual rate of new aneurysm formation in patients with previous 
SAH is 0.8-2% per year (Juvela et al., 1993; David et al., 1999; Tsutsumi et al., 
2001; Bederson et al., 2009; Sprengers et al., 2009). Patients with multiple 
intracranial aneurysms, hypertension, young age at the time of SAH, and smokers 
have a higher risk for de novo aneurysm formation (Bederson et al., 2009). 
2.1.9.2 Angiographic follow-up 
Angiographic follow-up is not routinely done for clipped aneurysms. However, 
coiled aneurysms need follow-up, but the recommendable length of follow-up has 
not been established. Age of the patient, comorbidities, size and shape of the 
aneurysm, location, rupture state and initial occlusion grade are taken into account 
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when deciding the follow-up duration. Sprengers et al. (2008) suggested that 
adequately occluded aneurysms at six months after coiling do not need imaging 
follow-up, except aneurysms that are partially thrombosed or larger than 15mm. 
Other aneurysms need long-term follow-up (Sprengers et al., 2008). However, some 
researchers argue that at least three years follow-up is mandatory for all coiled 
aneurysms (Raymond et al., 2003). 
 
2.1.10 Rebleeding 
2.1.10.1 Risk of rupture in previously unruptured aneurysms 
Unruptured aneurysms have an annual risk of rupture of 0-10%, depending on the 
aneurysm size, location and patient history of previous SAH (Table 13) (Juvela et 
al., 1993; Investigators, 1998; Juvela et al., 2000; Wiebers et al., 2003). The 
cumulative bleeding rate in a Finnish study was 10.5% at 10 years, 23% at 20 years 
and 30% at 30 years after the diagnosis of unruptured aneurysm (Juvela et al., 
1993). The median time between discovery of an unruptured aneurysm and SAH 
was 9.6 years (Juvela et al., 1993). Rupture risk is higher among posterior 
circulation aneurysms than anterior circulation aneurysms and among larger 
aneurysms (Wiebers et al., 2003; Clarke et al., 2005). Risk of hemorrhage is also 
higher in patients with previous SAH than in patients with no SAH (Investigators, 
1998; Juvela et al., 2000; Wiebers et al., 2003). In an ISUIA study, 1692 patients 
with unruptured aneurysms were followed up without treatment and 3% of them had 
SAH during the mean follow-up of 4.3 years (Wiebers et al., 2003). Table 14 shows 
rupture risks for anterior and posterior circulation aneurysms according to ISUIA. 
Overall annual bleeding rate was 0.8% (Wiebers et al., 2003). 
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Table 13. Annual risk of hemorrhage from unruptured aneurysms according to 
Mitchell et al., (2004). 
 Incidental aneurysm Additional aneurysm 
<7mm 0.1 0.4 
7-12mm 1.5 0.8 
13-24mm 2.7 1.2 
>24mm 5.3 - 
 
Table 14. Annual risk of hemorrhage from unruptured aneurysms according to size 
and location in ISUIA study (Wiebers et al., 2003).  
 
Size/location <7mm 7-12mm 13-24mm >25mm 
 no SAH 
 
previous 
SAH 
   
Anterior 0 0.3 0.52 2.9 8 
Posterior/ACoP 0.5 0.68 2.9 3.68 10 
ACoP=Posterior communicating artery; SAH= Subarachnoid hemorrhage 
2.1.10.2 Rebleeding after SAH conservative treatment 
The risk of rebleeding is highest within the first day after initial bleeding with a 
rebleeding rate approximately 15%, Figure 3 (Winn et al., 1977; Hijdra et al., 1987; 
Fujii et al., 1996). Another rebleeding peak is seven days after SAH and rebleeding 
rate within two weeks is 20% and within one month 30-40% (Hijdra et al., 1987; 
Fujii et al., 1996). Notably, within six months, 40-50% of conservative treated SAH 
patients have a rebleeding episode. After the first month the risk decreases gradually 
from 1–2%/day to 3%/year (Winn et al., 1977; Fujii et al., 1996; Juvela et al., 2000).  
The mortality after rebleeding is high and thus early management is preferable 
(Ohman and Heiskanen, 1989; Kassell et al., 1990a). The rate of early rebleeding is 
higher in cases with ventricular drainage, poor clinical grade and large aneurysm 
size (Pare et al., 1992). Conservative prevention methods of rebleeding are pain 
management, sedation, and control of hypertension (Feigin and Findlay, 2006). 
Antifibrinolytic therapy with tranexamic acid reduces rebleedings by about 60% but 
has been linked to increased risk for delayed cerebral ischemia in some studies and 
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results are not ambiguous (Torner et al., 1981; Hillman et al., 2002; Roos et al., 
2003).  
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Figure 3. Rebleeding rate in different time periods in SAH patients treated 
conservatively. 
 
2.1.10.3 Rebleeding after aneurysm clipping 
The risk of rebleeding is lower after surgical clipping than endovascular coiling 
(Molyneux et al., 2005). Rebleeding rate after successful surgical clipping is 1-3% 
in 10 years and the annual risk is 0.3-0.9% (Tsutsumi et al., 1998; David et al., 
1999; Tsutsumi et al. 2001; Molyneux et al., 2005; Wermer et al., 2005; van Gijn et 
al., 2007; Fulkerson et al., 2009). That is more than 20 times the risk of SAH in the 
general population (Wermer et al., 2005). Rebleeding risk is higher in incompletely 
than in completely treated aneurysms (David et al., 1999). Other risk factors for 
rebleeding are smoking, female gender, young age and multiple aneurysms at the 
time of the initial SAH (David et al., 1999; Juvela et al., 2001; Wermer et al., 2005).  
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2.1.10.4 Rebleeding after aneurysm coiling 
Overall rebleeding rate after coiling is 3% (Molyneux et al., 2005). Rebleeding is 
highest within the first weeks following treatment and such early rebleeding within 
30 days after treatment is detected in approximately 1% of SAH patients (Vanninen 
et al., 1999; Molyneux et al., 2005; Sluzewski and van Rooij, 2005; Willinsky et al., 
2009). Late rebleeding rate is between 0.5% to 2.6% (Kuether et al., 1998; Byrne et 
al., 1999; Kremer et al., 2002; Ng et al., 2002; Raymond et al., 2003; Kole et al., 
2005; Sluzewski et al., 2005; Ries et al., 2007; Willinsky et al., 2009). Incomplete 
occlusion and aneurysm size are risk factors for rebleeding (Kuether et al., 1998; 
Raymond et al., 2003). The largest studies reporting rebleeding rates after 
endovascular coiling are gathered in Table 15. 
2.1.10.5 Bleeding after treated unruptured aneurysms 
The bleeding rate in treated, unruptured aneurysms is not widely studied and most 
studies report no bleedings after coiling (Roy et al., 2001; Goddard et al., 2002). In a 
study of Standhardt et al. (2008), three (1.5%) out of 202 unruptured aneurysms 
ruptured after embolization during a 12-year follow-up. All three aneurysms were 
partially thrombosed giant posterior circulation aneurysms (Standhardt et al., 2008). 
In a review by Lanterna et al. (2004), 13 postprocedural bleedings occurred in 703 
patients (1.8%) and overall annual bleeding rate was 0.9% (95% CI, 0.41-1.4%). 
Only incompletely coiled aneurysms more than 10mm in size bled after coiling 
(Lanterna et al., 2004). 
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Table 15. Rebleeding rates after coiling. 
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Lanterna et al., 2004 U    0.9 review 
Gruber et al., 1999  R+U 79.2  2  6.7 2.5 giant 
Eskridge and Song, 
1998 
R  2 3.3   
Eskridge and Song, 
1998  
U  2  4.1   
Murayama et al., 1999  U 1255 1  1.3 0.08  
Kuether et al., 1998  R+U  1  1.4 0.7 *)  
Ng et al., 2002  R+U  2   1.5  
Willinsky et al., 2009 R 691 8 2.1 1.2  
Byrne et al., 1999 R 590 4 1.3  no after 3 yrs  
Raymond et al., 2003 R+U - 3 0.8   
Thornton et al., 2002 R+U  1 0.8   
Ries et al., 2007  R+U - 7 2.2   
Sluzewski et al., 2005 R 1559 5 1.3 0.3  
Holmin et al., 2008 R+U 1810 1 0.2 0.06  
Kremer et al., 2002 R 270 2 2,5 0.7  
Kole et al., 2005 R+U 448 2 1.5 0.5  
Koivisto et al., 2000 R 52 1 1.9 1.9  
Friedman et al., 2003 R 131 0 0 0  
Molyneux et al., 2005 R 3258 52 3.3 1.1  
van Rooij et al., 2009 R+U 94 2 1.1 2.1 <4mm 
Schaafsma et al., 2009 R 1778 3 1.1 0.2 adequately 
coiled 
R=Ruptured aneurysm; U=Unruptured aneurysm 
*) 0% in completely coiled, 2.6% (1.4%/yr) in incompletely coiled 
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2.2 Subarachnoid hemorrhage of unknown etiology 
Etiology of subarachnoid bleeding may remain unclear despite repeated four-vessel 
angiography. Vascular abnormalities are identified in 2 to 24% of patients on repeat 
DSA, but in most of these patients the etiology of SAH remains unknown (Iwanaga 
et al., 1990; Farrés et al., 1992; Ronkainen and Hernesniemi, 1992; Kaim et al., 
1996; Schwartz and Solomon, 1996; du Mesnil de Rochemont et al., 1997; Urbach 
et al., 1998; Rogg et al., 1999; Topcuoglu et al., 2003; Jung et al., 2006; Little et al., 
2007; Andaluz and Zuccarello, 2008; Agid et al., 2010). Patients with this type of 
SAH have a more favourable prognosis than patients with aneurysmal SAH (Rinkel 
et al., 1991b; Schievink and Wijdicks, 1997).  
Patients can be classified according to the pattern of hemorrhage on initial CT. In 
two thirds of these patients the CT scan shows a perimesencephalic pattern of 
hemorrhage (i.e. blood around the midbrain). Patients with perimesencephalic type 
of bleeding have a good prognosis, and a repeated angiography is thought to be 
unnecessary (Rinkel et al., 1991b; du Mesnil de Rochemont et al., 1997). Some 
researchers have recommended changing the name "perimesencephalic SAH" to 
"pretruncal" SAH because blood is mainly located in the prepontine cistern. Patients 
with diffuse or anteriorly located blood on CT (i.e. nonperimesencephalic 
hemorrhage, aneurysmal pattern of bleeding) are thought to be at risk of rebleeding 
and repeated angiography is necessary (van Gijn et al., 1985; Rinkel et al., 1991b; 
Rinkel et al., 1993). Blood does not extend into the parenchyma in 
perimesencephalic pattern of hemorrhage and also seldom in aneurysmal pattern of 
hemorrhage (Rinkel et al., 1991b; Ruigrok et al., 2002). Rinkel et al. (1991a) found 
sedimented blood in lateral ventricles in 21% of patients. However, depending of 
the timing of the initial CT, classifying bleedings as perimesenchephalic or 
nonperimesencephalic is not reliable (Schwartz and Solomon, 1996).  
2.2.1 Anatomy 
In perimesencephalic hemorrhage, the blood is centered in the perimesencephalic 
cisterns, mostly in the prepontine and interpeduncular cisterns (Figure 4) (Hijdra et 
al., 1990; Ruigrok et al., 2002). The Liliequist membrane (Figure 5) forms the 
anterosuperior border of the interpeduncular cistern and a border between 
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interpeduncular cistern and the carotid cisterns laterally and the chiasmatic cisterns 
medially (Fushimi et al., 2003). Mesencephalic part of the Liliequist membrane 
forms the border between the interpeduncular and prepontine cisterns. The 
diencephalic membrane is thicker and is not perforated in minor bleedings. 
However, the interpeduncular cistern communicates with the carotid cisterns via 
crural cistern and blood in the carotid cistern is common in SAH of unknown 
etiology (Rinkel et al., 1991a). Mesencephalic part of the membrane of Liliequist is 
incomplete, allowing passage of the basilar artery and therefore perimesenchephalic 
bleeding is often seen in both interpeduncular and prepontine cisterns (Matsuno et 
al., 1988). Blood in the chiasmatic cistern is due to a high pressure bleeding and 
raises suspicion of aneurysmal etiology (Schwartz and Solomon, 1996). In 
conclusion, according to Rinkel et al. (1991a) perimesencephalic hemorrhage can 
extend into the crural, ambient and quadrigeminal cisterns, sometimes into the 
suprasellar cistern and proximal part of the interhemispheric fissure and Sylvian 
fissure, but not into the distal parts of the latter fissures. 
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Figure 4. Schematic illustration of basal cisterns. 
 
A=interhemispheric fissure 
B=lateral sylvian fissure 
C=basal sylvian fissure 
D=interpeduncular fissure and suprasellar cistern 
E=ambient cistern 
F=quadriceminal cistern 
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Figure 5. Membrane of Liliequist has diencephalic, mesencephalic and sellar part in 
the sagittal segment. 
2.2.2 Incidence 
Subarachnoid hemorrhage with normal cerebral angiography is seen in about 15% 
(9–30%) of spontaneous SAH cases (Gomez et al., 1989; Kawamura and Yasui, 
1990; Broderick et al., 1994; Schaller et al., 1996; McMahon and Dorsch, 1999; 
Pobereskin, 2001; Claassen et al., 2002; Andaluz and Zuccarello, 2008). 
Perimesencephalic hemorrhage constitutes 21-68% of all angiogram-negative SAH 
(van Gijn et al., 1985; Rinkel et al., 1990; Van Calenbergh et al., 1993; Tatter et al., 
1995, Agid et al., 2010). The overall annual incidence rate for perimesencephalic 
SAH is 0.5/100000 in the North American population and it is a rare condition 
compared to aneurysmal SAH (Flaherty et al., 2005). Incidence in aneurysmal 
bleeding in the Finnish population is higher than in other European countries (Sarti 
et al., 1991; Broderick et al., 1994; Ostbye et al., 1997; Cesarini et al., 1999; Ingall 
et al., 2000; Inagawa, 2001; Pobereskin, 2001; de Rooij et al., 2007; Koffijberg et 
al., 2008) but incidence of nonaneurysmal SAH is not well studied. Etiology for 
SAH was not found in 8.6-10% of SAH in two early Finnish studies (Juvela, 1992; 
Ronkainen and Hernesniemi, 1992). 
Mesencephalic part 
Diencephalic part 
 
Sellar part 
56 
2.2.3 Pathogenesis 
The cause of angiogram-negative SAH has not been established and various 
pathogenetic mechanisms, such as venous or capillary bleeding (Wijdicks and 
Schievink, 1997; Watanabe et al., 2002; Mathews et al., 2008), a ruptured 
perforating artery (Kuker et al., 1999), a low-flow vascular malformation, or a short-
segment arterial dissection (Kuker et al., 1999; van der Schaaf et al., 2004; Mathews 
et al., 2008) have all been postulated. The only anatomically unique vascular 
structure in the prepontine and interpeduncular cisterns is the basilar artery, not 
veins or perforating arteries, which are found throughout the major intracranial 
subarachnoid cisterns (Schievink and Wijdicks, 2000). However, there are no 
variations in the configurations of the BA which could explain the origin of a 
hemorrhage (Lang et al., 2003). Some researchers think this entity does not exist at 
all, but reasons for not detecting aneurysms include spontaneous thrombosis, 
vasospasm, destruction of the aneurysm by hemorrhage, narrowing of the 
aneurysmal neck, alterations in blood flow, inadequate angiographic techniques or 
observer error (McMahon and Dorsch, 1999; Little et al., 2007; van Rooij et al., 
2008; Park et al., 2009). Microaneurysms were detected as a source of the 
hemorrhage in exploration or 3D-angiography in 10 out of 53 patients (19%) in 
cases of CTA and conventional angiograms were negative (Tatter et al., 1995; Park 
et al., 2009). However, although imaging methods have been developed a lot, there 
are still subarachnoid bleedings with unknown etiology. 
2.2.4 Clinical presentation 
Symptoms in patients with SAH of unknown etiology are similar to aneurysmal 
SAH: sudden onset of headache, meningismus, photophobia and nausea. However, 
symptoms are milder and consciousness is usually not lost (van Gijn et al., 1985; 
Rinkel et al., 1991b; Agid et al., 2010). Patients with both perimesencephalic and 
non-perimesencephalic hemorrhages have Hunt and Hess grade I or II in 74-94% of 
cases (Schwartz and Solomon, 1996; Brilstra et al., 1997). “Warning leaks” are 
detected in 13% of patients compared to 37% in aneurysmal bleedings (Juvela, 
1992). 
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Studies report a mean age of 50 years and there is no female predominence (van 
Gijn et al., 1985; Schievink et al., 1994; Schwartz and Solomon, 1996; Agid et al., 
2010). Patients with nonaneurysmal SAH have less hypertension and smoke less 
than aneurysmal SAH patients (Canhao et al., 1999; Lang et al., 2003; Flaherty et 
al., 2005; Agid et al., 2010). However, multivariate analysis confirmed that 
hypertension is an independent vascular risk factor also associated with 
perimesencephal SAH (Canhao et al., 1999). 
2.2.5 Diagnosis 
2.2.5.1 CT 
CT is usually immediately performed on admission and blood can be detected with a 
perimesencephalic pattern of SAH, with a nonperimesencephalic pattern of SAH or 
CT may be normal. Fisher grade is often lower than in patients with aneurysmal 
SAH (Schwartz and Solomon, 1996). The chance of finding an aneurysm is less 
than 5% in patients with a perimesencephalic pattern of hemorrhage (Rinkel et al., 
1991a; Pinto et al., 1993; Velthuis et al., 1999; Kershenovich et al., 2006; Brinjikji 
et al., 2010). Nonperimesencephalic SAH can further be classified as diffuse 
aneurysmal pattern and peripheral sulcal pattern. Peripheral sulcal nontraumatic 
SAH without blood in the basal cisterns raises a suspicion of vasculitis or 
coagulation disorders which are found in a third of cases (Little et al., 2007; Agid et 
al., 2010). Aneurysmal type bleeding means that blood is diffusely distributed 
throughout the basal cisterns and extends distally into the Sylvian fissures, into the 
ventricles and seldom into the parenchyma.    
Initial CT shows no blood in 9-65% of cases, depending on the timing of the 
initial CT (Gomez et al., 1989; Iwanaga et al., 1990; Van Calenbergh et al., 1993; 
Schwartz and Solomon, 1996; Urbach et al., 1998; Rogg et al., 1999; Lang et al., 
2003; Topcuoglu et al., 2003; Little et al., 2007). Complete washout of blood is seen 
in 92% of cases one week after ictus, and scans obtained >3 days after bleeding 
cannot reliably identify different patterns of hemorrhage (Schwartz and Solomon, 
1996).  
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Diagnosis is confirmed by cerebrospinal fluid analysis if initial CT is normal. 
However, lumbar puncture should be done more than six hours and preferably 12 
hours after the headache onset to differentiate true SAH from a traumatic lumbar 
puncture (van Gijn et al., 2007). 
MR imaging is not widely used at the acute stage after SAH (Wijdicks et al., 
1998b Topcuoglu et al., 2003; Little et al., 2007). However, in some studies MRA 
demonstrated the cause of SAH even when repeated DSA studies were negative 
(Rogg et al., 1999; White et al., 2000; Morita et al., 2001). 
2.2.5.2 Angiography 
CTA is performed at the acute stage and if the initial angiogram is negative, DSA is 
usually performed for detection of initially unrecognised aneurysms. 3D rotational 
angiography may help to detect small aneurysms (van Rooij et al., 2008). 
Angiography is usually repeated one week after the first angiogram and an 
aneurysm can be detected in approximately 10% (0-24%) of those cases (Kaim et 
al., 1996; du Mesnil de Rochemont et al., 1997; Urbach et al., 1998; Rogg et al., 
1999; Topcuoglu et al., 2003; Jung et al., 2006; Little et al., 2007). An aneurysm 
could be found in a second angiogram in 0% of patients with normal CT on 
admission, 0-7% in patients with perimesencephalic SAH and 4-46% in patients 
with non-perimesencephalic SAH (Kaim et al., 1996; Urbach et al., 1998; Rogg et 
al., 1999; Topcuoglu et al., 2003; Jung et al., 2006; Little et al., 2007). Many 
researchers thus recommend that in cases with a clear perimesencephalic 
hemorrhage pattern, a negative CTA is enough to rule out intracranial aneurysms 
and DSA is done only if CTA results are unsure (Velthuis et al., 1999; Ruigrok et 
al., 2000; Kershenovich et al., 2006; Agid et al., 2010). However, patients who have 
nonperimesencephalic SAH need repeated angiography (McMahon and Dorsch, 
1999; Hashimoto et al., 2000; van Dijk et al., 2001; Topcuoglu et al., 2003; Jung et 
al., 2006; Agid et al., 2010). A second angiogram is also needed when the initial CT 
scan is performed many days after the ictus and washout of blood may have 
occurred. Some centres also do a third angiography at six to eight weeks to exclude 
a thrombosed aneurysm (McMahon and Dorsch, 1999; Topcuoglu et al., 2003; Little 
et al., 2007). 
59 
2.2.6 Complications 
2.2.6.1 Vasospasm 
Radiographic vasospasm is seen in up to 20% of patients with angiogram-negative 
SAH, but symptomatic vasospasm is a rare complication (Gomez et al., 1989; 
Schaller et al., 1996; Wijdicks et al., 1998a; Madureira et al., 2000; Schievink et al., 
2000; Franz et al., 2001; Lang et al., 2003; Topcuoglu et al., 2003; Andaluz and 
Zuccarello, 2008). Cerebral vasospasm is related to the amount of blood noted on 
the primary CT scan (Wijdicks et al., 1998a). 
2.2.6.2 Hydrocephalus 
There is a positive correlation between acute hydrocephalus and the amount of 
subarachnoid blood in the initial CT (Jartti et al., 2004). Thus, ventricular 
enlargement is a more common complication after aneurysmal bleeding than after 
perimesencephalic bleeding. Incidences of hydrocephalus are 4-18% in 
perimesencephalic bleeding and 7-26% in nonperimesencephalic bleeding. 
However, a permanent CSF drainage system is rarely needed. (Wijdicks et al., 
1998a; Madureira et al., 2000; Franz et al., 2001; Lang et al., 2003; Andaluz and 
Zuccarello, 2008; Beseoglu et al., 2010) 
2.2.6.3 Rebleeding 
Rebleeding rate is considerably lower than in aneurysmal SAH. Rebleeding rate in 
patients with non-perimesencephalic bleeding is between 2 and 5%. Patients with 
perimesencephalic bleeding have lower rebleeding rates, with non-existing rates in 
recent studies (Greebe and Rinkel, 2007; Little et al., 2007). 
2.2.7 Management 
There is no specific treatment for patients with nonaneurysmal SAH. Symptomatic 
care, cardiac and serum chemistry monitoring and symptoms of hydrocephalus are 
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followed (Schwartz and Solomon, 1996; Wijdicks et al., 1998a). There is no proof 
about efficacy of bed rest, blood pressure control, and hypertensive or hypervolemic 
therapy, or about calcium channel blockers in achieving a better prognosis 
(Schwartz and Solomon, 1996; Wijdicks et al., 1998a). Surgical exploration is not 
indicated if adequate angiography has been performed (Schievink et al., 1994; Tatter 
et al., 1995; Schaller et al., 1996). 
2.2.8 Outcome 
Outcome in patients with nonaneurysmal SAH is significantly better than in patients 
with aneurysmal bleeding (Jain et al., 1987; Gomez et al., 1989; Kawamura and 
Yasui, 1990; Rinkel et al., 1991b; Juvela, 1992; Ronkainen and Hernesniemi, 1992; 
Schaller et al., 1996; Madureira et al., 2000; Franz et al., 2001; Lang et al., 2003; 
Greebe and Rinkel, 2007; Andaluz and Zuccarello, 2008; Beseoglu et al., 2010). 
Good outcomes are reported in 64-100% of patients and mortality is 0-15% (Jain et 
al., 1987; Gomez et al., 1989; Kawamura and Yasui, 1990; Rinkel et al., 1991b; 
Juvela, 1992; Ronkainen and Hernesniemi, 1992; Schaller et al., 1996; Madureira et 
al., 2000; Franz et al., 2001; Lang et al., 2003; Greebe and Rinkel, 2007; Andaluz 
and Zuccarello, 2008; Beseoglu et al., 2010). In patients with perimesencephalic 
SAH, the outcome is better than in nonperimesencephalic patients with 89-100% of 
good outcomes and less than 2% mortality (Van Calenbergh et al., 1993; Franz et 
al., 2001; Andaluz and Zuccarello, 2008; Beseoglu et al., 2010; Alfieri A et al., 
2011). The outcomes do not differ in patients with SAH on initial CT or in CT 
negative cases (Van Calenbergh et al., 1993). Although outcome is good, when 
assessed with Glasgow outcome scale, up to 72% of patients with nonaneurysmal 
SAH have neuropsychological deficits, depressive symptoms and symptoms 
including headaches, dizziness, fatigue, forgetfulness or irritability, even years after 
bleeding (Madureira et al., 2000; Greebe and Rinkel, 2007). Brilsta et al. (1997) 
reported that quality of life and capacity to work is not reduced in patients with 
perimesencephalic hemorrhage. Patients with an aneurysmal pattern of hemorrhage 
have a high cerebrovascular morbidity and poorer long-term outcome than patients 
with perimesencephalic SAH (Hawkins et al., 1989; Ruigrok et al., 2002; Alfieri A 
et al., 2011). Long-term mortality in patients with perimesencephalic SAH does not 
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differ from that observed in the general population (Gomez et al., 1989; Greebe and 
Rinkel, 2007).  
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3. Aims of the study 
The purpose of the present study were 
 
 
I To evaluate the long-term occlusion grade in aneurysms treated with 
endovascular coiling. 
 
II To evaluate the permanent focal changes of the brain tissue after 
endovascular treatment for both ruptured and nonruptured aneurysms. 
 
III  To assess the long-term mortality compared with the general population 
among patients with unruptured aneurysms with no previous SAH, and to compare 
mortality after coiling, clipping and without treatment. 
 
IV To assess the incidence, clinical findinds, long-term outcome and long-term 
MRI and MRA findings in patients with SAH of unknown origin. 
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4. Materials and methods 
4.1 Patient population 
All hospital records of patients with a diagnosis of “SAH” or “unruptured 
aneurysm” in Tampere University Hospital between 1989 and 1999 were reviewed. 
A total of 1571 patients were scrutinized, and 313 patients were excluded because of 
a false diagnosis, SAH caused by trauma, AVM, mycotic or dissecting aneurysm, 
and patients under 18 years old. All the included patients were treated either because 
of SAH (1,154) or unruptured aneurysms (307), at the neurosurgical department at 
Tampere University Hospital. Of those, 617 patients with 513 ruptured and 189 
unruptured intracranial aneurysms were treated, and 185 patients with 200 
aneurysms were treated with endovascular coiling. Figure 6 summarizes the 
included and excluded patients.  
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Figure 6. Flowchart summarizing the included and excluded patients.  
MRI= Magnetic resonance imaging; SAH=Subarachnoid hemorrhage; SAH NOS= 
Subarachnoid hemorrhage not otherwise specified 
1571 hospital 
records scrutinized 
1294 patients 
included 
313 excluded 
1154 SAH 
patients 
 
307 patients with 
unruptured aneurysms 
97 SAH NOS 
 
513 patients with  
ruptured aneurysm treated 
189 unruptured 
aneurysms treated 
76 patients 
coiled 
404 patients 
clipped 
109 patients 
coiled 
 
51 deceased 
34 studied by 
MRI 
12 deceased 
41 studied by 
MRI 
13 deceased 
33 studied by 
MRI 
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4.1.1 Patients with embolized aneurysms 
 
The study population consisted of 185 patients treated with endovascular coiling 
between 1992 and 1999. Coiling was performed in 109 patients with ruptured 
aneurysms and 76 patients with unruptured aneurysms (Figure 6). A total of 63 
patients had died at the time of follow-up. The clinical outcome could be evaluated 
in 116 (95%) out of the 122 surviving patients. The surviving patients (except for 26 
excluded patients) were contacted by letter proposing an MRI investigation. Patients 
were excluded if they lived outside our hospital catchment area or had 
contraindications to MRI. In study II, patients who also had one or more aneurysms 
clipped, were excluded.  Seventy-seven patients were examined with MRI and MRA 
approximately 11 years after initial coiling (range 9-16 years). Follow-up time was 
792 patient-years in the unruptured group and 688 patient-years in the ruptured 
group. The demographic data of patients studied with long-term follow-up MRI is 
shown in Table 16. 
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Table 16. Baseline characteristics of the patients with long-term follow-up of 
embolized aneurysms (% in parenthesis). 
 
Patients with ruptured 
aneurysms 
Patients with unruptured 
aneurysms 
 n=34 n=43 
Male/Female 15/19 15/28 
Mean age, years (range) 54 (34-73) 50 (21-79) 
Number of aneurysms   
   1 26 29 
   2 6 10 
   3 2 4 
Number of aneurysms coiled 34 50 
Indication for angiography   
   SAH 34 (100) 7 (16) 
   familial history of SAH - 4 (9) 
   cranial nerve dysfunction - 4 (9) 
   incidental - 28 (65) 
H&H at the time of diagnosis   
   I 12 (35) - 
   II 12 (35) - 
   III 6 (18) - 
   IV 4 (12) - 
   V 0 - 
Fisher grade   
   1 3 (9) - 
   2 1 (3) - 
   3 9 (26) - 
   4 9 (26) - 
   Missing 12 (35) - 
GOS at discharge   
   1 0 0 
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   2 1 (3) 0 
   3 7 (21) 2 (5) 
   4 16 (47) 10 (23) 
   5 10 (29) 31 (72) 
GOS at follow-up   
   1 0 0 
   2 0 0 
   3 3 (9) 6 (14) 
   4 8 (24) 13 (30) 
   5 23 (68) 24 (56) 
Aneurysm location   
   ICA 2 (6) 20 (40) 
   MCA 3 (9) 14 (28) 
   ACoA 13 (38) 5 (10) 
   ACoP 3 (9) 1 (2) 
   ACA/pericallosa 2 (6) 5 (10) 
   Vertebrobasilar circulation 11 (32) 5 (10) 
Aneurysm size   
   <7mm 27 (79) 29 (58) 
   7-12mm 5 (15) 16 (32) 
   13-24mm 2 (6) 3 (6) 
   ≥25mm 0 2 (4) 
Initial angiographic result   
   complete 14 (41) 24 (48) 
   neck remnant 9 (26) 10 (20) 
   incomplete 11 (32) 16 (32) 
ACA=Anterior cerebral artery; ACoA=Anterior communicating artery; ACoP=Posterior 
communicating artery; GOS=Glasgow outcome scale; H&H=Hunt&Hess scale; 
ICA=Internal carotid artery; MCA=Middle cerebral artery; SAH=Subarachnoidal 
hemorrhage 
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4.1.2 Unruptured aneurysms in patients with no previous SAH 
Between 1989 and 1999, 140 patients with 178 intracranial unruptured aneurysms 
without previous SAH were admitted to Tampere University Hospital. Patients (75 
women and 65 men) were aged 18-86 years (mean 54 yrs) at the time of diagnosis 
of the unruptured intracranial aneurysm. A total of 66 out of 178 aneurysms were 
left untreated, 64 were treated with endovascular coiling and 48 were treated 
surgically (Figure 7). All patients were followed up until death or the end of April 
2011 and no patients were lost from follow-up. Fifty out of 140 patients (36%) had 
died during the 1702 patient-year follow-up period. 
 
Treatment methods for unruptured aneurysms
37 %
36 %
27 %
No treatment Embolization Surgery
 
Figure 7. Distribution of treatment methods for unruptured aneurysms in patients 
without previous SAH. 
4.1.3 SAH of unknown etiology 
The study IV population consisted of 97 patients with SAH of unknown etiology. 
Patients older than 18 were included if SAH was diagnosed by CT or by positive 
lumbar puncture and no vascular pathologies were detected in repeated four-vessel 
cerebral angiography or in postmortem examinations. SAH was diagnosed by 
computed tomography (CT) in 80 (82%) cases and xanthochromia of the CSF in 17 
(18%) cases. The diagnosis was based on DSA in 96 patients and postmortem 
examinations on one patient. The demographic data is shown in Table 17. 
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Table 17. Demographics of patients with SAH of unknown etiology. 
 
 Surviving group Deceased group 
 N=84 N=13 
Mean age (years) 52 53 
Male/Female 31/53 4/9 
Diagnosis   
  CT 67 13 
  Lumbar puncture 17 0 
Fisher grade   
  1 16 0 
  2 17 4 
  3 20 5 
  4 23 4 
  Missing 8 - 
Hydrocephalus 30 4 
Hunt&Hess grade   
  I 40 2 
  II 32 2 
  III 10 5 
  IV 1 3 
  V 1 1 
GOS at discharge   
  I  0 2 
  II 0 1 
  III 10 1 
  IV 41 7 
  V 33 2 
GOS at follow-up   
  I  0 13 
  II 0 0 
  III 4 0 
  IV 18 0 
  V 62 0 
GOS=Glasgow outcome scale 
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4.2 Data collection 
All hospital records, CT scans, MR-images and DS-angiograms were studied 
retrospectively. The surviving patients in study groups I, II and IV living in the 
hospital catchment area were contacted by letter proposing an MRI investigation, 
and were then interviewed to assess clinical outcome and possible rebleeding 
episodes. A total of 110 were interviewed and studied with MRI and MRA between 
2007 and 2008. Surviving patients not studied with MRI either lived outside the 
hospital catchment area (n=22), did not answer the invitation letter (n=13), were 
unwilling to participate in the study (n=6) or had contraindications to MRI (n=4). 
The latest outcome of patients was evaluated by telephone interview, or from the 
latest notes in the hospital records. A total of 504 out of 1294 patients were 
deceased, and death certificates were obtained from Statistics Finland to ascertain 
the date and cause of death. 
4.3 Embolization procedures 
Endovascular procedures were performed in cases where the aneurysm seemed to be 
treatable in a consensus meeting of an interventional radiologist and a neurosurgeon. 
Procedures were performed between 1992 and 1999. Aneurysms were embolized 
with platinum Guglielmi detachable coils (GDC, Target Therapeutics, Fremont 
Calif., USA). Intravenous nimodipine was used routinely and 5000 IU 
unfractionated heparin was given intravenously before coiling in unruptured cases 
and after two coils in ruptured cases. 
4.4 Follow-up 
The clinical outcome was evaluated using the Glasgow Outcome Score (GOS, Table 
9) (Jennett and Bond, 1975). Mean follow-up time of patients studied with MRI was 
11 years (median 9 yrs, range 9-18yrs). Patients studied with MRI were interviewed 
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and the clinical outcome was assessed using both GOS and GOSE (Wilson et al., 
1998). The latest outcome was evaluated from the latest notes in the hospital records 
or by telephone interview in patients not studied with MRI. Possible rebleeding 
episodes were elicited. In studies I, II and IV, patients were followed up until death, 
until the last MRI or phone contact or latest hospital records between 2007 and 
2008. In study III the patients were followed up until death or the end of April 2011.  
4.5 Imaging protocol 
The follow-up MR imaging was performed with 1.5 T unit (GE Signa HD, 
Milwaukee, Wisc., USA) with 1-channel head-coil. The MRA was supplemented 
with cross-sectional imaging including FLAIR and T2* weighted sequences mainly 
to detect ischemic parenchyma, the size of the CSF spaces and signs of persistent 
blood degradation deposits. The imaging parameters for the non-contrast 3D time-
of-flight angiography were: TR 30, TE 2.5, FOV 22 x 16.5 cm, slice thickness 1.0 
mm/interpolated to 0.5 mm, matrix 320 x 224. Magnetization transfer contrast and 
flow compensation were included. The imaging parameters for the FLAIR were: TR 
9001 ms, TE 125 ms, TI 2250 ms, FOV 22 cm, slice thickness 5/1mm, matrix 224 x 
256, NEX 1 and for T2* weighted images: TR 460 ms, TE 20 ms, flipangle 20°, 
FOV 22 cm, slice thickness 5/1mm, matrix 160 x 256 (interpolated to 512), NEX 2. 
Areas of increased signal intensity of vascular territories in T2* weighted images 
were considered as infarctions. Small high signal foci on T2* weighted images were 
considered as leukoaraiosis. 
All radiological images were reviewed independently by a neuroradiologist, an 
interventional radiologist and a neurosurgeon and thereafter a consensus statement 
for each study was made. Primary CT images were re-evaluated to assess Fisher 
grades, existence and grade of ventricular enlargement and possible parenchymal 
lesions. Previous MRI and MRA studies were compared with the present images. 
Aneurysm neck and fundus sizes were measured and dome-neck ratios were 
calculated. The degree of aneurysm occlusion was classified according to the 
modified Raymond’s classification (Figure 2) (Raymond et al., 1997) and also as 
loose or dense, the former meaning that there was opacification between coils and 
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the latter meaning no contrast media was detected between coils. Parenchymal 
lesions were considered aneurysm-related if they appeared during acute 
hospitalization; aneurysmal ICH was seen in primary CT or detected in parental 
artery territory after the treatment period. Infarctions in MRI were divided into 
parental and non-parental artery territory infarctions.  
4.6 Statistical analysis 
Statistical analysis was performed using NCSS (NCSS, Kaysville, Utah, USA) 
statistical software. Categorical variables were compared using Fisher exact two-
tailed test. Continuous variables between groups were compared using the Mann-
Whitney U-test or Student T-test. The level of significance was set at p<0.05. 
Correlation between variables was analyzed with Spearman’s rank correlation test. 
Excess mortality of the patients was measured by one minus relative survival ratio 
(RSR). The RSR is the ratio of the actuarial observed survival proportion divided by 
the expected survival proportion of a comparable group of the Finnish general 
population matched for sex, age and calendar time. The expected survival 
proportions were estimated by Ederer II method (Ederer, Heise 1959). Relative 
survival measures the survival experience of the patients corrected for competing 
risks of death. Relative survival ratios were estimated by survival package SURV3 
version 3.01 (Finnish Cancer Registry, Helsinki, Finland). Differences in relative 
survival between patient groups were tested applying likelihood ratio tests 
(Hakulinen et al. 1987). 
4.7 Ethical issues 
The present study was approved by the Ethics Committee of Tampere University 
Hospital and Statistics Finland. Informed consent was obtained from all patients 
studied with MRI.  
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5. Results 
5.1 Long-term occlusion grade after endovascular 
coiling 
Long-term follow-up MRAs showed complete occlusion in 18 ruptured aneurysms 
(53%), 11 (32%) had neck remnants and 5 (15%) were graded as incomplete (Figure 
8). Unruptured aneurysms (Figure 9) were graded as complete in 20 (40%) 
aneurysms, neck remnant in 11 (22%) and incomplete in 18 (38%). Unruptured 
aneurysms were incompletely occluded more often than ruptured ones, and this 
difference reached statistical significance (p=0.03). Although incomplete occlusion 
was seen in 23 aneurysms (27%), only three had poorer occlusion grades than in 
previous follow-up images. Table 18 shows the stability of aneurysms in both 
groups. A change to a better occlusion grade (i.e. progression) was detected in 17% 
of aneurysms. Stable occlusion was detected in 60% of aneurysms, 14% had 
remnant growth and 8% had recurrence at long-term follow-up MRI. Incompletely 
occluded aneurysms were monitored for many (up to ten) years after the initial 
treatment and when the occlusion grade was assessed to be stable, follow-up images 
were discontinued. Four of these incompletely coiled aneurysms are still being 
followed up. Incompletely occluded aneurysms had wider necks and fundi than 
aneurysms with a higher occlusion grade.  No de-novo aneurysms were detected. 
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Figure 8. Distribution (%) of occlusion grades after treatment and at long-term follow-
up MRI in ruptured aneurysms.  
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Figure 9. Distribution (%) of occlusion grades after treatment and at long-term follow-
up MRI in unruptured aneurysms.  
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Table 18. Changes in aneurysm occlusion grade after initial treatment and long-term 
follow-up images in ruptured and unruptured group. 
 
 Ruptured aneurysms Unruptured aneurysms 
 n=34 n=49 
Progression 7 (21%) 7 (14%) 
Stable 20 (59%) 30 (61%) 
Recanalization 7 (21%) 12 (24%) 
5.2 Long-term MRI findings after endovascular coiling 
5.2.1 Ruptured aneurysms 
Parenchymal lesions of various causes (infarctions or previous ICH) were detected 
in 14 (44%) SAH patients and 18 (56%) had normal brain parenchyma on T2-
weighted MR images (Figure 10). High signal intensity lesions on T2-weighted 
images indicating infarction in the vascular territory of the aneurysm were seen in 
six (19%) SAH patients. Four patients (13%) had infarctions in vascular territories 
other than that of ruptured aneurysms (non-parental artery territories) and three (9%) 
of them were considered to be caused by vasospasm. All aneurysm-related lesions 
were detected during the initial treatment period, and no aneurysm-related delayed 
infarctions were seen. Figures 11 and 12 show typical examples of aneurysm-related 
lesions detected. 
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Figure 10. Number of parenchymal lesions in SAH group. 
ICH=Intracerebral hemorrhage; SAH=Subarachnoid hemorrhage 
 
 
Figure 11. Large left side occipital infarction (white arrow) nine years after 
thromboembolic complication during endovascular coiling of a ruptured BA 
aneurysm. Infarction was detected during initial hospitalization.  
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Figure 12. Small cerebellar infarctions (white arrows) detected after coiling of a 
ruptured right vertebral artery aneurysm without any clinical complications during 
acute hospitalization 13 years earlier. 
5.2.2 Unruptured aneurysms 
Normal brain parenchyma was detected in 21 (66%) patients with unruptured 
aneurysms in long-term follow-up MRIs (Figure 13). Parenchymal high signal 
intensity lesions on T2-weighted MR images were detected in 11 (34%) patients 
with unruptured aneurysms. Infarction in the vascular territory of the aneurysm was 
seen in six (19%) patients and two of them were not detected during the treatment 
period. One of them was caused by coil migration without any clinical symptoms, 
and the other was probably caused by delayed embolic complications after a treated 
giant ICA aneurysm.   
Non-parental artery infarctions occurred in six (19%) patients, and these lesions 
were not aneurysm-related: four infarctions were detected before aneurysm 
treatment and two were detected years after the coiling.  
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Figure 13. Number of parenchymal lesions in patients with embolized unruptured 
aneurysms. 
5.3 Long-term excess mortality of patients treated for 
unruptured intracranial aneurysms 
5.3.1 Untreated aneurysms 
Patients with untreated unruptured aneurysms had excess long-term mortality 
compared to the general population (Figure 14). The five year cumulative RSR was 
0.78 among males and 0.56 among females with untreated unruptured aneurysms, 
implying 22% and 44% excess mortality, respectively. The 10 year cumulative RSR 
was 0.80 in males and 0.49 in females with untreated aneurysms. The 15 year 
cumulative RSR was 0.50 among both males and females with untreated unruptured 
aneurysms, implying 50% excess mortality.  
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Figure 14. Cumulative observed and expected survival proportions in males and 
females with no treatment of unruptured aneurysms. Adapted from Pyysalo et al. 
(2012).   
5.3.2 Clipped aneurysms 
Mortality among surgical group did not differ from the general population at a five 
year follow-up, neither did it in males after 10 years (Figure 15). However, women 
had 8% excess mortality after a 10 year follow-up, and 28% excess mortality after 
15 years (RSR: 0.72) compared with the matched Finnish population. Males had 8% 
excess mortality at 15 years (RSR: 0.88) in the surgical group.  
 
 
 
Figure 15. Cumulative observed and expected survival proportions in males and 
females after surgery. Adapted from Pyysalo et al. (2012). 
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5.3.3 Coiled aneurysms 
Men with embolized aneurysms had no excess mortality when compared to the 
matched Finnish male population (Figure 16). However, women had 19% excess 
mortality at a five year follow-up, and 23% excess mortality at 15 year follow-up, 
respectively. Mortality among women over 50 years of age was higher than in 
coeval men. Both genders under 50 years of age had a 15 year cumulative RSR of 
around 0.90, but the 15 year cumulative RSR in patients over 50 years differed 
significantly between men (0.91) and women (0.49, p=0.018). 
 
 
Figure 16. Cumulative observed and expected survival proportions in males and 
females after embolization. Adapted from Pyysalo et al. (2012). 
5.3.4 Causes of death in patients with unruptured aneurysms 
Fifty out of the 140 patients (36%) had died during the 1702 patient-years follow-up 
period. Half of the deaths (48%) were cerebrovascular events and 58% of them 
occurred within five years after diagnosis (Figure 17). Eleven patients died of 
cardiovascular diseases (22% of deaths), six of malignancies (12% of deaths) and 
eight due to other causes (16% of deaths). The cause of death in one patient was 
stroke with unverified etiology. Patients with treated aneurysms were less likely to 
die from neurologically related causes than patients with untreated aneurysms; 32% 
and 61%, respectively. Figure 18 shows causes of death in study III compared to 
other studies and the Finnish general population. 
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Figure 17. Number of deaths and distribution of causes of deaths in every follow-up 
year. 
 
 
Figure 18. Causes of death in study III compared to other studies. Type of strokes 
were not differentiated in a study by Wiebers et al. (2003) neither in statistics of death 
causes in Finnish population. 
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5.4 Nonaneurysmal SAH 
5.4.1 Clinical condition of patients with nonaneurysmal SAH 
Most patients were in good clinical condition on admission (80% H&H 1-2) and 
94% of surviving patients had a good recovery (GOS 4-5) after a mean follow-up 
time of 12 years (range 9-18yrs, Figure 19). There were no rebleedings.  
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Figure 19. Present GOS of patients with SAH of unknown etiology. 
GOS=Glasgow outcome scale 
5.4.2 Mortality of patients with nonaneurysmal SAH 
Thirteen out of the 97 patients (13%) had died during the follow-up period (mean 12 
years, range 9-18 years, 868 patient-years). Four of them (4%) had died from the 
initial bleeding of nonaneurysmal SAH: two immediately and another two in one 
month after poor clinical state. All four patients had severe bleeding on the initial 
CT (Fisher 3 or 4, nonperimesencephalic type of bleeding). Clinical condition on 
admission and Fisher grade on primary CT were predisposing factors for poor 
outcomes. Three patients died of cardiovascular diseases, three of malignancies, and 
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three due to traumatic causes. Mortality in the first year after the bleeding was 4% in 
excess of that expected in a comparable group from the general population. 
Thereafter, mortality of the patients was close to the level of the general population. 
5.4.3 Long-term MRI and MRA findings in patients with 
nonaneurysmal SAH 
Thirty-three patients were studied with MRI and MRA. Neither new aneurysms nor 
other vasculopathies which could explain the previous SAH were detected in MRA 
images. Six patients (18%) had infarctions in MRI. Two of them were already seen 
during the treatment period after clinically and radiologically proven vasospasm. 
Four infarctions were not detected in earlier images, and only two of those four 
patients had been treated for clinical stroke. Leukoaraiosis was seen in 11 (34%) 
patients. Signs of superficial hemosiderin were still present in two patients (6%).  
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6. Discussion 
Tampere University Hospital started endovascular coiling procedures for cerebral 
aneurysms in 1992, and it has become a routine treatment method; 50% of all 
treated aneurysms are coiled nowadays. The present study has a very long follow-up 
period with most of the treated patients included (792 patient-years in the 
unruptured group and 688 patient-years in the ruptured group). 
6.1 Long-term occlusion grade after embolization 
We found unfavourable occlusion grades in embolized aneurysms; 27% of 
aneurysms were incompletely occluded. Most of those angiographic results would 
not be accepted in the clinical practice today because endovascular techniques have 
developed markedly since the early 90’s. Regardless of these unfavorable 
angiographic occlusion grades, most aneurysms have remained stable during follow-
up and only three aneurysms were retreated following this study. Unruptured 
aneurysms were less well occluded than ruptured aneurysms in the follow-up 
angiogram and this is probably because of lower packing density at the initial 
treatment. No recurrences occurred in completely occluded ruptured aneurysms and 
complete occlusion should be the aim of the treatment to prevent recurrences and 
the need for subsequent follow-up images. This concurs with earlier studies 
(Raymond and Roy, 1997; Kuether et al., 1998; Holmin et al., 2008; Sprengers et 
al., 2008; Schaafsma et al., 2009).  
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6.1.1 Does coiling prevent rebleedings? 
Earlier studies have reported rebleeding rates of coiled, ruptured aneurysms to be 
between 0% and 6.5% (Cognard et al., 1999; Gruber et al., 1999; Ng et al., 2002; 
Willinsky et al., 2003). The annual rebleeding rate in earlier reports is between 0% 
and 3.5% (Cognard et al., 1999; Gruber et al., 1999; Willinsky et al., 2003). In 
present study annual rebleeding rate was 1.3% and concurs thus with earlier studies. 
Risk of recurrence of a completely clipped aneurysm is 0.3-0.9% per patient-year 
(Tsutsumi et al., 2001; Fulkerson et al., 2009) and both treatment methods prevent 
rebleedings, especially after proper occlusion.  
6.2 Parenchymal lesions after endovascular coiling 
6.2.1  Ruptured aneurysms 
Aneurysm-related parenchymal lesions are frequent, 40% in study II and as high as 
57% infarction rates found in earlier studies (Hadjivassiliou et al., 2001; Bendel et 
al., 2008). However, infarction rates after surgical clipping are even higher, up to 
89% (Hadjivassiliou et al., 2001; Kivisaari et al., 2001; Koivisto et al., 2000; Bendel 
et al., 2008). Lesions develop during the acute hospitalization so prevention of 
rebleeding by clipping or coiling is not enough, but effort should further be made to 
prevent cerebral infarctions caused by vasospasm or treatment related 
thromboembolic complications. Although 5 out of 14 patients (36%) with 
radiological infarction were asymptomatic, patients with infarction have poorer 
clinical outcome than patients with no ischemic lesions in MRI. Lesion volume is 
detected to correlate with the neuropsychological test performance in previous study 
by Bendel et al. (2008).  
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6.2.2 Unruptured aneurysms 
In study II, 19% of patients had aneurysm-related parenchymal lesions in MRI, 
which compares favourably with earlier studies (Debrum et al., 1998; Roy et al., 
2001).  Many infarctions detected in MRI were not aneurysm-related and were 
instead reason to detect the incidental unruptured aneurysms.  Four out of 32 (13%) 
patients had clinical aneurysm-related ischemic events during the treatment period, 
but treatment of unruptured aneurysms did not cause permanent deterioration in 
outcomes. Two out of 32 (6%) patients had aneurysm-related infarction after the 
treatment period. These late parental artery territory infarctions were uncommon 
although occlusion grade was incomplete in 36% of cases and thus incomplete 
occlusion does not seems to add risk for late embolic complications.  
6.3 The excess long-term mortality among patients with 
unruptured aneurysms 
The long-term survival among patients with unruptured aneurysms has been studied 
in only one large, administrative database study (Britz et al., 2004). It was stated in 
that study that survival among SAH patients was lower than among patients with 
unruptured aneurysms, but after the first year post clipping, differences in the 
survival rate diminished (Britz et al., 2004). However, there are no studies about 
long-term survival among patients with endovascularly treated unruptured 
aneurysms.  
 The majority of deaths in patients with unruptured aneurysms were 
attributable to cerebrovascular and cardiovascular diseases, supporting the 
hypothesis that aneurysmal disease is part of a more generalized vascular disease 
and excess long-term mortality is related to aneurysm formation, not SAH as 
previously found (Ronkainen et al., 2001; Huttunen et al., 2011). Patients with 
untreated unruptured aneurysms had a higher mortality rate than patients with 
treated aneurysms and this difference has been noticed in a previous study 
supporting treatment of unruptured aneurysms (Britz et al., 2004). 
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 We found that women had lower relative survival than men. Male patients 
treated with endovascular coiling or surgical clipping had no significant difference 
in mortality compared to the general matched population. However, women had 
20% excess mortality in endovascular and 28% excess mortality in the surgical 
group at the 15 year follow-up. The reason for this is unclear and further studies 
with larger patient groups are needed.  
6.3.1 Should unruptured aneurysms be treated? 
The ISUIA study reported annual rupture rate of 0.1% in patients with unruptured 
aneurysms of less than 7mm in diameter and without previous SAH (Wiebers et al., 
2003). Rupture risk is so low that the overall treatment risks have been thought to 
outweigh the treatment benefits. In the present study, 56% of unruptured aneurysms 
were less than 7mm, raising the question as to if the treatment of these was pointless 
or even harmful to patients. It is suggested that patients should have a life 
expectance more than 13-20 years before the treatment would be beneficial 
(Mitchell et al., 2004). Patients with unruptured aneurysms are not, however, 
comparable to the general population, because they have excess mortality compared 
to age, sex and calendar time matched population. In addition, aneurysm rupture 
incidence is much higher in Finland than in other western countries and thus 
treatment strategy for unruptured aneurysms should possibly differ in Finland. 
The mortality of the patients with treated unruptured aneurysms did not differ 
significantly between endovascular and surgical groups, supporting the opinion that 
unruptured aneurysms can either be coiled or clipped. However, patients with 
untreated, unruptured aneurysms had a significantly higher mortality than patients 
with treated aneurysms. The same was found by Britz et al. (2004). In both studies, 
higher mortality among untreated and treated may be attributable to bias. 
Conservatively treated patients may be older, may have more comorbidities, may 
smoke more etc. The difference between treated and untreated aneurysm patients 
was found also after adjusting age and comorbidities supporting the treatment of 
unruptured aneurysms (Britz et al., 2004).  
Despite infarctions in 34% of unruptured patients, treatment of unruptured 
aneurysms did not cause permanent deterioration in outcome. Taken that into 
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account, treatment of patients with unruptured aneurysms without previous SAH 
may be indicated if life expectancy is more than one decade and patient have risk 
factors to bleeding (smoking, hypertonia, heavy alcohol consumption etc.).   
6.4 SAH of unknown etiology 
  
Study IV is the only study in the modern imaging era to assess the long-term 
outcome of patients with SAH of unknown etiology. Perimesencephalic bleeding is 
just a subgroup of SAH of unknown etiology (SAH NOS, SAH NAS, kryptogenic 
SAH etc.) and even term perimesencephalic SAH is not exact. Therefore Schievink 
and Wijdicks (1997) have suggested the term pretruncal SAH to be more correct. 
However, such terminological snobbism is not relevant in clinical practise because 
blood distribution is related to time between bleeding and imaging, and some 
patients are diagnosed late after bleeding. Some researchers do not believe this 
diagnosis at all, but think there is a tiny aneurysm which is not found. However, 
patients with nonaneurysmal SAH have more benign disease than patients with 
aneurysmal SAH, supporting different etiology of bleeding. Most patients (81%) in 
Study IV recovered well (GOS 4 or 5) and poor outcome was related to SAH in only 
six (6%) patients. Infarctions were detected in six (18%) patients, which is 
significantly less than in patients with aneurysmal SAH (Kivisaari et al., 2001; 
Bendel et al., 2008). We found no rebleedings, no vasculopathies explaining 
previous SAH and no excess mortality compared to age-and gender matched general 
population. The risk of death from nonaneurysmal bleeding was 4% in present study 
and compares favourable with earlier studies reporting risk of death 0-15% (Jain et 
al., 1987; Gomez et al., 1989; Hawkins et al., 1989; Kawamura and Yasui, 1990; 
Rinkel et al., 1990; McMahon and Dorsch, 1999; Lang et al., 2003; Greebe and 
Rinkel, 2007; Andaluz and Zuccarello, 2008). Overall mortality was 13% compared 
with 47% mortality in aneurysmal SAH patients at the same time.  
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7. Conclusions 
1)  Coiled unruptured aneurysms showed incomplete occlusion grades in 37% 
of cases. However, the annual bleeding rate was as low as 0.1%. 
Endovascular treatment of ruptured aneurysms showed incomplete 
angiographic outcomes in 15% of cases and annual rebleeding rate was 
1.3%. Occlusion grades were stable in most cases, but long-term imaging 
follow-up is needed after endovascular coiling. 
 
2)  Parenchymal lesions in brain tissue seen on postoperative MRI are common. 
Aneurysm-related parenchymal lesions were seen in 41% SAH patients and 
in 19% of patients with unruptured aneurysms. Most lesions were detected 
during the acute treatment period and aneurysm-related infarctions after the 
treatment period are uncommon. 
 
3) Patients with untreated, unruptured aneurysms have excess long-term 
mortality compared to the general population. The majority of deaths, 48%, 
were caused by cerebrovascular diseases. Treatment of unruptured 
aneurysms is associated with a decreased risk of death, and survival does not 
differ between patients with coiled and clipped aneurysms. Men with coiled 
unruptured aneurysms have a survival rate comparable to that of the general 
matched population and only 8% excess mortality in the surgical group. 
Women have excess mortality after both surgical and endovascular treatment 
of unruptured aneurysms. 
 
4) Patients with SAH of unknown etiology have a better long-term outcome 
than patients with aneurysmal SAH. There is a 4% excess mortality during 
the first year after SAH and thereafter mortality is on the same level as the 
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comparable general population. There is no risk of rebleeding and long-term 
follow-up MRI is not needed. 
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Summary
Long-term follow-up studies after endovascu-
lar treatment for intracranial aneurysm are still 
rare and inconclusive. The aim of this study was 
to assess long-term clinical and angiographic 
outcome of patients with endovascularly treated 
aneurysms.
The  Clinical outcome of all 185 patients with 
endovascularly treated aneurysms were ana-
lyzed and 77 out of 122 surviving patients were 
examined with MRI and MRA nine to 16 years 
(mean 11 years) after the initial endovascular 
treatment. 
Sixty-three patients were deceased at the time 
of follow-up. The cause of death was aneurysm-
related in 34 (54%) patients. The annual re-
bleeding rate from the treated aneurysms was 
1.3% in the ruptured group and 0.1% in the un-
ruptured group. In long-term follow-up MRA 
18 aneurysms (53%) were graded as complete, 
11 aneurysms (32%) had neck remnants and 
five aneurysms (15%) were incompletely oc-
cluded in the ruptured group. Occlusion grade 
was lower in the unruptured group with 20 an-
eurysms (41%) graded as complete, 11 (22%) 
had neck remnants and 18 (37%) were incom-
plete. However, only three aneurysms were un-
stable during the follow-up period and needed 
retreatment. 
Endovascular treatment of unruptured aneu-
rysms showed incomplete angiographic out-
come in 37% of cases. However, annual bleed-
ing rate was as low as 0.1%. Endovascular treat-
ment of ruptured aneurysms showed incomplete 
angiographic outcome in 15% of cases and the 
annual rebleeding rate was 1.3%. 
Introduction
Endovascular coiling has been increasingly 
used for intracranial aneurysm occlusion since 
its introduction in 1991. Our hospital started 
endovascular treatment in 1989 and the first 
coiling with Guglielmi detachable coils (GDCs) 
was done in 1992. Nowadays in our institution 
70% of aneurysms are coiled. While short and 
mid-term results are encouraging for endovas-
cular procedures, there are still only few long-
term follow-up studies 1-4. In approximately 
20% of patients, the coiled aneurysm reopens 
in follow-up 2,5-8. Thus, delayed bleeding rate af-
ter endovascular coiling is slightly higher than 
after surgical clipping 1,2,9,10. The aim of this 
study was to assess the long-term angiographic 
results after endovascular coiling and to ascer-
tain rebleeding rate for embolized aneurysms. 
Materials and Methods
Patient population: A total of 617 patients 
with 513 ruptured and 189 unruptured intracra-
nial aneurysms were treated between 1992 and 
1999. Of these, 185 patients with 200 aneurysms 
were treated with endovascular coiling. Coiling 
was done for 109 patients with ruptured aneu-
rysms and 76 patients with unruptured aneu-
rysms (Figure 1). Endovascular procedures 
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was 792 patient-years in the unruptured group 
and 688 patient-years in the ruptured group. 
Data collection: All hospital records, cerebral 
images and angiograms were evaluated retro-
spectively. Death certificates were examined to 
ascertain the date and cause of death. Surviving 
patients were contacted by letter proposing an 
MRI investigation. A total of 77 patients were 
examined neurologically and studied with MRI 
and MRA (magnetic resonance angiography) 
between the years 2007 and 2008. The clinical 
outcome evaluation was done with the Glas-
gow Outcome Score (GOS). Surviving patients 
not imaged by MRI were interviewed by phone 
and GOS was assessed and possible rebleeding 
episodes were elicited. The study was approved 
by the Hospital Ethics Committee and all pa-
tients gave their informed consent to the study. 
Imaging protocol: The follow-up MR imag-
ing was performed with a 1.5 T unit (GE Signa 
HD, Milwaukee, USA) with a one channel head 
coil. The MRA was supplemented with cross-
were carried out in cases where the aneurysm 
seemed to be treatable in the estimation of the 
endovascular radiologist and neurosurgeon. 
Aneurysms were embolized with platinum 
Guglielmi detachable coils (GDC, Target Ther-
apeutics, Fremont California, USA)  and peri-
procedural medication was 5000 IU unfraction-
ated heparin intravenously before coiling in 
unruptured cases and 5000 IU unfractionated 
heparin intravenously after two coils in rup-
tured cases. Intravenous nimodipine was used 
routinely. A total of 63 patients were deceased 
at the time of follow-up. Clinical outcome could 
be evaluated from 116 (95%) out of 122 surviv-
ing patients. Surviving patients, except 26 pa-
tients excluded were contacted by letter pro-
posing an MRI investigation. Patients were ex-
cluded if they lived outside our hospital catch-
ment area or had contraindications to MRI. 
Seventy-seven patients were examined with 
MRI and MRA approximately 11 years after 
initial coiling (range 9-16 years). Follow-up time 
A B
Figure 1  A,B)  Flow chart summarizing the included and excluded patients in ruptured (A) group and unruptured (B) group.
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the ruptured group and internal carotid artery 
in the unruptured group. The ruptured group 
had more posterior circulation aneurysms than 
the unruptured group and this difference was 
statistically significant (p=0.02). Aneurysm 
mean size was 4.7 mm in the ruptured group 
and 6.3 mm in the unruptured group. Size var-
ied more in the unruptured group and aneu-
rysms tended to be bigger and have higher fun-
dus-neck ratio than ruptured aneurysms but the 
difference was not statistically significant 
(p=0.16). Primary occlusion grade did not differ 
between ruptured and unruptured aneurysms 
(p=0.7). However, packing density differed sig-
nificantly between the groups (p=0.04) being 
denser in the ruptured group. Angiographic oc-
clusion grade and packing density were not re-
lated to the locations of aneurysms (p>0.7). 
There was a weak negative correlation between 
aneurysm size and occlusion grade (rho -0.3, 
p<0.03). Aneurysms, with fundi less than 5 mm, 
were totally occluded in 46% of cases whereas 
aneurysms over 10 mm wide were completely 
occluded in only 29% of cases.
Retreatment: Retreatment was provided for 
27 patients with ruptured aneurysms (25%) 
and for 16 (21%) patients with unruptured an-
eurysms. Retreatment within 6 months after 
initial coiling was done for 15 (56%) patients 
with ruptured aneurysms and for eight (50%) 
patients with unruptured aneurysms. Nineteen 
(70%) patients with ruptured aneurysms were 
retreated once, three (11%) were retreated 
twice, three (11%) patients were retreated 
three times and one (4%) patient five times 
and one (4%) patient six times. Ten (63%) pa-
tients with unruptured aneurysms were retreat-
ed once, five (30%) patients were retreated 
twice and one (6%) patient was retreated six 
times. Retreated aneurysms were larger than 
others: mean fundus diameter was 7.8 mm com-
pared to 4.8 mm in aneurysms treated only 
once. The aneurysm neck was also wider in re-
treated aneurysms than in once treated aneu-
rysms (mean 3.6 mm compared to 2.8 mm). 
Rebleedings: There were ten postprocedural 
bleedings in all 185 endovascularly treated pa-
tients. Nine out of 109 SAH patients and one 
out of 75 patients with unruptured aneurysms 
bled after coiling procedure (Odds ratio 6.7, 
95% CI 0.9 to 295.8, p=.05). One (1.3%) large 
unruptured aneurysm bled seven years after in-
complete coiling. The annual bleeding rate was 
0.1% in the unruptured group. Two patients 
were lost to follow-up and the bleeding rate, as-
sectional imaging including FLAIR, T1 and 
T2* sequences mainly to detect ischemic pa-
renchyma, size of the CSF spaces and superfi-
cial siderosis. The imaging parameters for the 
non-contrast 3D time-of-flight angiography 
were: TR 30, TE 2.5, FOV 22×16.5 cm, slice 
thickness 1.0 mm/interpolated to 0.5 mm, ma-
trix 320×224. Magnetization transfer contrast 
and flow compensation were included.
Imaging assessment: The diagnostic, proce-
dural and follow-up angiograms were reviewed 
independently by a neuroradiologist, an inter-
ventional radiologist and a neurosurgeon. 
Thereafter the results were reviewed and a 
consensus statement for each study was made. 
Aneurysm neck and fundus sizes were meas-
ured and dome-neck ratio was calculated. The 
degree of aneurysm occlusion was classified ac-
cording to modified Raymond’s classification 2 
as follows: complete occlusion, neck remnant 
and incomplete occlusion. Treatment result was 
also classified as loose or dense, the former 
meaning that there was opacification between 
coils and the latter meaning no contrast media 
was detected between coils. 
Statistical analysis: The patient population 
was divided into two different groups: ruptured 
and unruptured aneurysms. Statistical analysis 
was performed using NCSS (NCSS, Kaysville, 
Utah, USA) statistical software. Categorical 
variables were compared using Fisher’s exact 
two-tailed test. Continuous variables between 
groups were compared using the Mann-Whit-
ney U-test or Student T-test. The level of sig-
nificance was set at p<0.05. Correlation be-
tween variables was analyzed with Spearman’s 
rank correlation test.
Results
Part I 
Outcome of all endovascularly treated patients
Population characteristics: A total of 109 pa-
tients with ruptured aneurysms and 76 patients 
with unruptured aneurysms were treated with 
endovascular coiling. Unruptured aneurysms 
were detected because of previous SAH (sub-
arachnoid hemorrhage) in 14 patients (18%). 
Nine (12%) were studied because of a family 
history of SAH. Forty-two (55%) were detected 
incidentally and 11 (14%) presented with cra-
nial nerve dysfunction. The anterior communi-
cating artery was the most frequent location in 
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tient was vegetative. Four patients were lost to 
clinical outcome. A total of 31 (55%) patients 
with unruptured aneurysms had a GOS score 
of 5 and 16 (29%) patients had a GOS score of 
4. Nine patients (16%) were dependent after 11 
years of follow-up. Two patients with unrup-
tured aneurysms were lost to clinical follow-up. 
The poor outcome in patients with unruptured 
aneurysms was related to aneurysm in three 
patients only. 
Part II 
A subgroup analysis of 77 patients studied with 
MRI
Follow-up angiographic results: MR imaging 
was done for 34 patients with ruptured aneu-
rysms and 43 patients with unruptured aneu-
rysms (Table 2) more than nine years after the 
coiling procedure. MRA showed complete oc-
clusion in 18 aneurysms (53%) in the ruptured 
group and 20 aneurysms in the unruptured 
group (40%). Angiographic results could not be 
evaluated from one patient because of artifacts 
in MRI. Eleven ruptured aneurysms (32%) and 
11 (22%) unruptured aneurysms had neck rem-
nants in MRA. Five aneurysms (15%) in the 
ruptured group and 18 (38%) in the unruptured 
group were graded as incomplete. 
A change to a better occlusion grade (i.e. 
progression) was detected in seven (21%) rup-
tured aneurysms, 20 (59%) were stable, six 
(18%) had remnant growth and one (3%) had 
recurrence in the follow-up MR images (Figure 
2). In the unruptured group, seven (14%) aneu-
rysms progressed, 30 (61%) were stable, six 
suming these had rebleedings, was 3.9% (0.4% 
annual bleeding rate). 
Nine ruptured aneurysms rebled (8.3%). Four 
rebleedings (3.7%) occurred within five weeks 
after coiling and five aneurysms (4.6%) rebled 
more than four years after initial treatment. One 
aneurysm was completely occluded, three had 
neck remnant and five were incompletely oc-
cluded in the post-procedural angiogram. Only 
three aneurysms were monitored after treat-
ment. The reason for this was advanced patient 
age or poor clinical outcome after initial treat-
ment. All but one patient died from rebleeding. 
The annual rebleeding rate was 1.3%. Four pa-
tients were lost to follow-up and bleeding rate, 
assuming all those had rebleedings, was 11.9% 
(annual bleeding rate 1.9%).
Mortality: Thirty-four (54%) out of 63 de-
ceased patients died due to aneurysmal disease 
(Table 1). Eighteen patients with ruptured an-
eurysms died from acute SAH, one patient died 
from treatment complications, one patient from 
brain infarcts caused by vasospasm and two pa-
tients survived many months in poor clinical 
outcome and the cause of death was primary 
SAH. Three (5%) patients died from bleeding 
of aneurysms that were left untreated before. 
Nine (14%) patients died from rebleeding. 
Twenty-nine (46%) out of 63 deceased patients 
died from diseases not related to aneurysm. 
Clinical outcome of all patients: Most surviv-
ing SAH patients were in good clinical condi-
tion after follow-up: 34 (57%) patients had a 
GOS score of 5, and 12 (20%) patients had a 
GOS score of 4. Thirteen patients (22%) were 
dependent (GOS score of 3) and one (2%) pa-
Patients with SAH Patients withunruptured aneurysms
Aneurysmal disease 32  2
Other cerebral diseases  4  2
Other cardiovascular diseases  9  3
Cancer  4  2
Respiratory  1  0
Trauma  1  0
Other  0  3
Total 51 12
Table 1  Cause of death of the 63 deceased patients
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low-up MRI, but because of the voluntary na-
ture of the study, we could reach only 79% of 
included patients. Those patients we could not 
reach may be in poorer clinical condition and 
unable or unwilling to participate. However, 
this selection bias is unlikely to influence the 
angiographic occlusion grades. To the best of 
our knowledge, this series has the longest fol-
low-up period published with most of the treat-
ed patients included (792 patient-years in the 
unruptured group and 688 patient-years in the 
ruptured group). 
We conducted this long-term follow-up study 
with MRI because it is noninvasive and cost-
effective compared to DSA (digital subtraction 
angiography) 12,13. The sensitivity of MRI has 
been demonstrated [14-16]. We studied patients 
with 1.5T rather than with 3.0T because they 
had previously been studied with 1.5T MRI as 
well in a study that ascertained the feasibility of 
MRA in our material 14. The follow-up images 
were thus comparable with each other.
Endovascular treatment is less frequently 
complete than surgical clipping of aneurysms. 
Furthermore, recurrences are more frequent. It 
has been shown that complete or near com-
plete occlusion of the aneurysm sac is sufficient 
to prevent rebleeding in 98% of cases treated 
in the acute phase of SAH 17. Conversely, the 
presence of a residual aneurysm is associated 
with subsequent bleeding 17,18. Neck remnant 
obliteration may be sufficient to protect against 
rebleeding after SAH, but the recurrence risk 
is higher, and longer follow-up is needed.
(12%) had remnant growth and six (12%) had 
recurrence. Although incomplete occlusion was 
seen in 23 aneurysms (27%), only three had 
poorer occlusion grade than in previous control 
images. Twenty incompletely occluded aneu-
rysms were monitored for many years after the 
initial treatment. If the occlusion grade was sta-
ble, follow-up images were discontinued. Four 
of these incompletely coiled aneurysms are still 
being followed-up. 
Unruptured aneurysms were more incom-
pletely occluded than ruptured ones and this 
difference reached statistical significance 
(p=0.03). Incompletely occluded aneurysms 
had wider necks and fundi than better occluded 
aneurysms. No de-novo aneurysms were de-
tected in this series. 
Only nine (36%) retreated aneurysms were 
graded as complete in MRA compared to 82 
(51%) of once-treated aneurysms. Neck rem-
nant was detected in eight (32%) and occlusion 
grade was incomplete in eight (32%) of retreat-
ed aneurysms. 
Discussion
Our institution started coil embolization in 
1992. In the early years of endovascular treat-
ment, coiling was mainly used for patients with 
high surgical risk 11. However, in our institution 
endovascular treatment was approved for 
standard treatment at an early stage. Our aim 
was to examine all surviving patients with fol-
Figure 2  A,B)  Changes in occlusion grades per aneurysm in the ruptured group (A) and in the unruptured group (B). Number 
on the right indicates number of cases.
A B
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Patients with ruptured
aneurysms
n=34
Patients with unruptured
aneurysms
n=43
Gender
Male 15 15
Female 19 28
Mean age (range) 54 years (34-73) 50 years (21-79)
Number of aneurysms
1 26 29
2 6 10
3 2 4
Number of aneurysms coiled 34 50
Reason for initial angiography
SAH 34 (100%) 7 (16%)
family history of SAH 4 (9%)
cranial nerve dysfunction 4 (9%)
incidental 28 (65%)
Hunt & Hess at the time of diagnosis
I 12
II 12
III 6
IV 4
V 0
Fisher 10 primary CT scans were missing
1 3
2 1
3 9
4 9
Intraventricular hemorrhage 2
Intracerebral hemorrhage 9
Hydrocephalus in primary CT 10
Aneurysm location
Anterior circulation
ICA 2 (6%) 20 (40%)
MCA 3 (9%) 14 (28%)
ACoA 13 (38%) 5 (10%)
ACoP 3 (9%) 1 (2%)
ACA/pericallosa 2 (6%) 5 (10%)
Vertebrobasilar circulation 11 (32%) 5 (10%)
Aneurysm size
≤5mm 23 (68%) 29 (58%)
6-10mm 9 (26%) 16 (32%)
>10mm 2 (6%) 5 (10%)
Initial angiographic result p=0.7
complete 14 (41%) 24 (48%)
neck remnant 9 (26%) 10 (20%)
incomplete 11 (32%) 16 (32%)
Packing density
densely occluded 22 (65%) 19 (38%)
Retreatment 13 (38%) 12 (28%)
GOS at follow-up
1 0 0
2 0 0
3 3 6
4 8 13
5 23 24
Table 2  Baseline characteristics of the 77 included patients
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after coiled, ruptured aneurysms to be between 
0% and 6.5% 5,11,21,22. The annual rebleeding 
rate in earlier reports is between 0% and 3.5% 
5,13,21,22. In our series annual rebleeding rate was 
1.3% and concurs with earlier studies. 
Only a few studies have reported delayed 
bleeding rates for coiled unruptured aneurysms 
11,23-25. Rates have varied from 0% to 2.4% 
19,23,25,26. The annual rupture rate in our series 
was 0.1%. The ISUIA study 27 reported annual 
rupture rate of 0.1% in patients with unrup-
tured aneurysms of less than 7 mm in diameter 
who had not had a previous SAH. The rupture 
risk is so low that the overall treatment risks 
outweigh the treatment benefits. In our series 
56% of unruptured aneurysms were less than 7 
mm raising a question if the treatment of these 
was pointless or even harmful to patients. How-
ever, it is difficult to believe that coiling increas-
es the risk for delayed bleeding in unruptured 
aneurysms. In our series 81% of ruptured aneu-
rysms were less than 7 mm and thus beside an-
eurysm size, inflammation of the aneurysm wall 
also seems to play important role in aneurysm 
degeneration and rupture 28,29.
Conclusions 
Endovascular treatment of unruptured aneu-
rysms had incomplete angiographic outcome in 
37% of cases. However, the annual bleeding 
rate was as low as 0.1%. Endovascular treat-
ment of ruptured aneurysms had incomplete 
angiographic outcome in 15% of cases and the 
annual rebleeding rate was 1.3%. 
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Earlier reports have discussed a wide variety 
in occlusion grades in earlier reports because 
anatomic results are subjective and difficult to 
standardize. Complete obliteration has previ-
ously been reported in 26%-88% of ruptured 
aneurysms, neck remnant in 18% to 50% and 
incomplete occlusion in 2% to 26% 5,8,9,17-20. In 
our study 27% of aneurysms were incompletely 
occluded and many of our angiographic results 
reported here would not be accepted today in 
our clinical practice. The aneurysms in our se-
ries were treated before the advent of newer 
techniques such as balloon-assisted remodeling, 
three-dimensional GDC or stents. These new 
techniques may decrease recurrence rates. 
Gallas et al. 21 found total or subtotal occlu-
sion in 97% of ruptured and unruptured aneu-
rysms. This is the best angiographic outcome 
published and better than in our series or in 
earlier published series 2,3. Complete occlusion 
or neck remnant was found in 63% of unrup-
tured aneurysms in our series and this is less 
than previously reported 3,19. Regardless of un-
favorable angiographic occlusion grades, most 
of these were stable in follow-up. Only three 
aneurysms out of 23 incompletely occluded 
cases were unstable in follow-up and were re-
treated after this study. No recurrences oc-
curred in completely occluded ruptured aneu-
rysms in our series. These results are compara-
ble to those of earlier reports 2-4,21.
Although the initial angiographic occlusion 
grade was similar in the ruptured and unrup-
tured groups, unruptured aneurysms had lower 
packing density. In the early years it was 
thought that change in flow would prevent 
bleeding. This is probably the reason why un-
ruptured aneurysms were less well occluded in 
the follow-up angiogram than ruptured aneu-
rysms. Retreatment was performed for 43 an-
eurysms (23%) which is higher than previously 
reported 5,8,9,17,18,20,21. 
Earlier studies have reported rebleeding rates 
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with Guglielmi detachable coils. J Comput Assist Tom-
ogr. 1999; 23: 216-223.
 17 Raymond J, Roy D. Safety and efficacy of endovascular 
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gery. 1997; 41: 1235-1245.
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767-778.
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angiography of intracranial aneurysms treated with en-
dovascular placement of Guglielmi detachable coils. 
Neurosurgery. 2002; 50: 239-249.
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rysms Investigators: Unruptured intracranial aneu-
rysms: natural history, clinical outcome, and risks of 
surgical and endovascular treatment. Lancet. 2003; 362: 
103–110.
 28 Frösen J, Piippo A, Paetau A, et al: Remodeling of sac-
cular cerebral artery aneurysm wall is associated with 
rupture - histological analysis of 24 unruptured and 42 
ruptured cases. Stroke. 2004; 35: 2287-2293.
 29 Tulamo R. Frosen J. Junnikkala S, et al: Complement 
activation associates with saccular cerebral artery an-
eurysm wall degeneration and rupture. Neurosurgery. 
2006; 59: 1069-1076..
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Abstract
Background: Long-term follow-up studies after endovascular treatment for intracranial aneurysm are still
rare and inconclusive. Parenchymal infarctions related to aneurysms have mostly been studied in patients
with subarachnoidal hemorrhage (SAH) but infarction rates in patients with endovascularly treated
unruptured aneurysms have been little studied.
Purpose: To determine the frequency of permanent parenchymal lesions as detected in magnetic resonance
imaging (MRI) in patients treated with endovascular coiling and to assess aneurysm-related infarctions after
the initial treatment period.
Material and Methods: A total of 64 patients (32 with primarily ruptured aneurysms) with 69 embolized
aneurysms were examined neurologically and by MRI and magnetic resonance angiography (MRA) more
than 9 years after the initial endovascular treatment.
Results: A total of 14 out of 32 (44%) SAH patients and 11 (34%) patients with unruptured aneurysms had
parenchymal lesions in MRI. Infarctions were detected in 10 (31%) SAH patients and the majority (9/10,
90%) of them were aneurysm-related. All aneurysm-related infarctions were detected at the acute
hospitalization stage. A total of six (55%) out of 11 infarctions in patients with unruptured aneurysms were
aneurysm-related and two of them appeared after the treatment period. Patients with infarction had poorer
clinical outcome than patients with no ischemic lesions in MRI.
Conclusion: Nineteen percent of patients with unruptured and 41%with ruptured aneurysms had aneurysm-
related parenchymal lesions in MRI. Most of these were detected during acute treatment period. Aneurysm-
related infarctions after treatment period are uncommon.
Keywords: CNS, interventional, MR imaging, embolization, aneurysms
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Morbidity after subarachnoid hemorrhage (SAH) is still
high despite developed treatment methods, anesthesiologi-
cal modalities, and intensive rehabilitation (1–7). Bleeding
itself, vasospasm or treatment-related causes can cause cer-
ebral lesions visible in computed tomography (CT) or mag-
netic resonance imaging (MRI). MRI is more sensitive for
detecting parenchymal lesions than CT (8, 9). Infarction
rate after aneurysmal SAH is as high as 79–89% in
clipped patients (8, 10–12). Aneurysm treatment with endo-
vascular coiling seems to be safer than clipping (10, 13) and
fewer infarctions are seen in coiled patients (10, 12).
Although lesions consistent with infarction seen in CT or
MRI sometimes appear extensive, patients may in fact be
asymptomatic (14, 15). The treatment of small unruptured
aneurysms is much debated because the International
Study of Unruptured Intracranial Aneurysms (ISUIA)
showed that surgical morbidity and mortality from unrup-
tured aneurysms was higher than risk of rupture for aneur-
ysms less than 10 mm over a 7.5-year period (16). Morbidity
related to endovascular coiling in unruptured aneurysms is
between 1.7 and 8.6% (16–20) and lower than in patients
receiving surgical treatment (16, 17, 21). The incidence of
parental artery infarction after unruptured aneurysm
coiling is not known. The aim of this study was to ascertain
the frequency of permanent parenchymal lesions as
detected in MRI in patients treated with endovascular
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coiling and to assess aneurysm-related infarctions after the
initial treatment period.
Material and Methods
Patient population
A total of 185 patients with 200 aneurysms were treated
between 1992 and 1999 with endovascular coiling in our
hospital (Fig. 1). Twenty patients had one or more aneur-
ysms clipped and were excluded from this study. A
further 22 patients living outside our hospital catchment
area were excluded because follow-up and possible re-treat-
ment was not done in our hospital. Endovascular pro-
cedures were done in cases where the aneurysm seemed
to be treatable in the estimation of the endovascular radiol-
ogist and neurosurgeon. Aneurysms were embolized with
platinum Guglielmi detachable coils (GDC, Target
Therapeutics, Fremont, CA, USA) and peri-interventional
medication was 5000 IU unfractionated heparin intrave-
nously before coiling in unruptured cases and 5000 IU
unfractionated heparin intravenously after two coils in rup-
tured cases. Intravenous nimodipine was used routinely.
The clinical status of patients with aneurysmal SAH was
assessed at the time of onset and treatment according to
the Hunt & Hess scale (H&H) (22). Glasgow Outcome
Score (GOS) (23) was used to evaluate clinical status at the
time of discharge and at follow-up visits.
A total of 63 patients were deceased at the time of
follow-up and 34 (54%) of them died due to aneurysmal
disease (Table 1). Sixteen patients were lost from MRI
follow-up either due to refusal to participate in follow-up
studies or to having contraindications to magnetic ﬁeld
studies. Sixty-four patients harbouring 72 aneurysms were
studied for more than 9 years after the initial coiling pro-
cedure (Table 2). Mean follow-up time was 11 years
(range 9–16 years, median 10). Sixty-nine aneurysms were
coiled and three were left untreated due to small size.
Thromboembolic events occurred in seven coiling pro-
cedures (10%) and coil migration in one (1%) case.
Neurological deterioration was detected in 15 procedures
(22%) and infarction veriﬁed by CT was seen in 11 cases
(16%). Three patients suffered re-bleeding in hospital
before treatment and aneurysmal rupture occurred in two
cases during coiling (3%). One patient (1%) re-bled 13
days after incompletely coiled aneurysm procedure.
Re-treatment was provided for 23 aneurysms (33%) from
one month to six years after the initial treatment (mean 15
months).
Data collection
All hospital records were studied retrospectively and all CT
scans, MR images and angiograms performed from 1992 to
2008 were analyzed. Preoperative CTs were done for 32
SAH patients and 15 patients with unruptured aneurysms.
Preoperative MRIs were done for two SAH patients and
21 patients with unruptured aneurysms. Postoperative CTs
during the acute stage of the disease were done for 17
SAH patients and seven patients with unruptured aneur-
ysms. Postoperative MRIs were done for four SAH patients
during the initial treatment period. Surviving patients
included were contacted by letter offering an MRI examin-
ation. A total of 64 patients were studied with MRI
between the years 2007 and 2008 and patients were inter-
viewed and examined neurologically by the author. The
study was approved by the Hospital Ethics Committee
and all patients gave their informed consent to the study.
Imaging protocol
The follow-up MR imaging was performed with 1.5 T unit
(GE Signa HD, Milwaukee, WI, USA) with 1-channel head-
coil. The MRA was supplemented with cross-sectional
imaging including ﬂuid attenuated inversion recovery
(FLAIR) and T2 weighted sequences mainly to detect
ischemic parenchyma, the size of the CSF spaces and
Table 1. Cause of death of the 63 deceased patients
Patients
with SAH
Patients with
unruptured
aneurysms
Aneurysmal disease: acute SAH 20 0
Aneurysmal disease: primary SAH after
long vegetative state
2 0
Aneurysmal disease: SAH from untreated
aneurysm
2 1
Aneurysmal disease: re-bleeding 8 1
Other cerebral diseases 4 2
Other cardiovascular diseases 9 3
Cancer 4 2
Respiratory 1 0
Trauma 1 0
Other 0 3
Total 51 12
Fig. 1 Flowchart summarizing the included and excluded patients
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signs of persistent blood degradation deposits. The imaging
parameters for the non-contrast 3D time-of-ﬂight angiogra-
phy were: TR 30, TE 2.5, FOV 22  16.5 cm, slice thickness
1.0 mm/interpolated to 0.5 mm, matrix 320  224.
Magnetization transfer contrast and ﬂow compensation
were included. The imaging parameters for the FLAIR
were: TR 9001 ms, TE 125 ms, TI 2250 ms, FOV 22 cm,
slice thickness 5/1 mm, matrix 224  256, NEX 1 and for
T2 weighted images: TR 460 ms, TE 20 ms, ﬂipangle 208,
FOV 22 cm, slice thickness 5/1 mm, matrix 160  256
(interpolated to 512), NEX 2. Areas of increased signal inten-
sity of vascular territories in T2 weighted images were con-
sidered as infarctions. Small high signal foci on T2
weighted images were considered as leukoaraiosis.
Imaging assessment
The diagnostic, procedural and follow-up images were
reviewed independently by a neuroradiologist, a neurointer-
ventionalist and a neurosurgeon. Thereafter, the results
were reviewed and a consensus statement for each study
was issued. MRI and MRA studies done prior to this
study were analyzed and compared with the present
study results. Primary CT images were re-evaluated to
assess Fisher grades, existence and grade of ventricular
enlargement and possible parenchymal lesions.
Parenchymal lesions were considered aneurysm-related if
they appeared during acute hospitalization, aneurysmal
ICH was seen in primary CT or detected in parental
artery territory after treatment period. Infarctions in MRI
were divided into parental and non-parental artery territory
infarctions.
Statistical analysis
Statistical analysis was performed using NCSS statistical
software (NCSS, Kaysville, UT, USA). Categorical variables
were compared using Fisher’s exact two-tailed test.
Continuous variables between groups were compared
using the Mann-Whitney U-test. The level of signiﬁcance
was set at p , 0.05.
Results
MRI findings at long-term follow-up
Parenchymal lesions
Ten years after embolization, 18 (56%) SAH patients and 21
(66%) patients with unruptured aneurysms showed normal
brain MRI. Parenchymal lesions on FLAIR images of differ-
ent cause (infarctions or previous ICH) were seen in 14
(44%) SAH patients (Fig. 2) and 11 (34%) patients with
unruptured aneurysms (Fig. 3).
Infarctions in the parental artery territory
Lesions on FLAIR images indicating infarction in the vascu-
lar territory of the aneurysm were seen in six (19%) SAH
patients and six (19%) patients with unruptured aneurysms
(Fig. 4). All but two of these lesions were detected during
Table 2. Population characteristics
MRI patients
with ruptured
aneurysms
(n 5 32)
MRI patients
with unruptured
aneurysms
(n 5 32)
Gender
Men 14 12
Women 18 20
Mean age at diagnosis (years) 53 49
Mean age at follow-up MRI
(years)
64 60
Preoperative diseases
Hypertension 10 10
Smoking history 17 13
Diabetes 0 1
Alcohol heavy user 4 5
Anticoagulant therapy 3 5
SAH in family 5 7
Reason for initial angiography
SAH 32
Familial history of SAH 7
Cranial nerve dysfunction 4
Incidental 21
Hunt & Hess
0 – 32
1 10 –
2 12 –
3 6 –
4 4 –
Fisher grade 9 primary CT
images were
missing
1 3 –
2 1 –
3 9 –
4 10 –
Hydrocephalus 10
External ventricular drainage 6
Aneurysm location
Anterior circulation 23 35
ICA 2 15
MCA 3 11
ACoA 13 5
ACoP 3 1
ACA/pericallosa 2 3
Vertebrobasilar circulation 9 2
Aneurysm size (mm)
,7 26 22
7–12 4 11
13–24 2 2
25 0 2
Initial angiographic result
Complete 13 14
Neck remnant 9 8
Incomplete 10 15
Present co-morbidities
No other illnesses 5 7
Depression 3 7
Epilepsy 2 3
Hypertension 19 10
COPD/asthma 2 3
Diabetes 2 1
Present GOS
3 2 3
4 7 11
5 23 18
ICA ¼ internal carotid artery; MCA ¼middle cerebral artery; ACoA ¼ anterior
communicating artery; ACoP ¼ posterior communicating artery; ACA ¼
anterior cerebral artery; COPD ¼ chronic obstructive pulmonary disease;
SAH ¼ subarachnoidal hemorrhage; GOS ¼ Glasgow Outcome Scale
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the treatment period (Fig. 5). Infarctions were detected in
patients who had either thromboembolic complications or
clinical or angiographic vasospasm and infarctions in CT
images. Two patients had infarctions in parental artery territory that were not detected during acute hospitaliz-
ation. One of these patients had a small infarction in
middle cerebral artery aneurysm territory without any clini-
cal defects after coil migration in primary treatment pro-
cedure. The other patient had two infarctions at separate
locations which occurred 10 years after primary stenting
and coiling and 3 years after re-embolization of a giant
ICA aneurysm.
Infarctions in other vascular territories
Brain infarctions in vascular territories other than that of the
ruptured aneurysm were seen in four (13%) SAH patients
and three (9%) of them were considered to be caused by
vasospasm. Six (19%) patients with unruptured aneurysms
Fig. 5 Aneurysm-related infarction rates
Fig. 3 Flowchart summarizing parenchymal lesions in patients with
unruptured aneurysms
Fig. 4 Fluid-attenuated inversion recovery image shows large infarction in
the left posterior cerebral artery territory caused by thromboembolic compli-
cation in coiling procedure
Fig. 2 Flowchart summarizing parenchymal lesions in SAH group
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had infarctions in non-parental artery territory. In four
(13%) of these the infarctions were detected by CT before
aneurysm treatment and in two patients years after the
coiling. None of them were considered to be aneurysm-
related.
Residual signs of hematoma and superficial siderosis
Signal intensity changes seen on FLAIR images due to pre-
vious ICH were detected in ﬁve (16%) SAH patients (Fig. 6).
Signs of superﬁcial siderosis were present in six (19%) SAH
patients.
Ventricular enlargement and leukoaraiosis
Five patients (8%) had ventricular enlargement.
Leukoaraiosis was seen in 25 (39%) patients: in 16 (50%)
patients with ruptured aneurysms and in nine (28%)
patients with unruptured aneurysms.
Clinical outcome
Most patients were in good clinical condition after
follow-up: 41 (64%) patients had a GOS score of 5 and 18
(28%) patients had a GOS score of 4. Only ﬁve patients
(8%) were dependent (GOS score of 3). GOS tended to be
lower in patients with unruptured aneurysms than in
patients with ruptured aneurysms but the difference was
not statistically signiﬁcant (p . 0.08). Poor outcome in
patients with unruptured aneurysms was related to aneur-
ysm in one patient only who had brainstem compression
caused by a large basilar aneurysm. In others the reason
for poor outcome was not related to aneurysms. Patients
with unruptured aneurysms had more depression but less
hypertension than patients with previous SAH (Table 2).
Other diseases and medication were comparable between
patients with ruptured and unruptured aneurysms.
Patients with infarction had poorer clinical outcome than
patients with no ischemic lesions in MRI (p, 0.05, Table 3).
Five out of 14 (36%) SAH patients with radiological infarc-
tion were asymptomatic. Four patients (29%) had global
deﬁcits and ﬁve patients (36%) had focal deﬁcits. Patients
with unruptured aneurysms and parenchymal lesions in
follow-up MRI were mostly (70%) asymptomatic. Only
three out of 11 patients (30%) had focal deﬁcits.
Discussion
Our aim was to determine the frequency of permanent par-
enchymal lesions in patients treated with endovascular
coiling and to assess aneurysm-related infarctions after the
initial treatment period. Thirty-four percent of patients
with unruptured aneurysms had infarctions in MRI and
19% were aneurysm-related. Patients with unruptured
aneurysms had high incidence of parenchymal lesions not
related to aneurysm because most aneurysms were found
incidentally during cerebral imaging for some neurological
symptoms other than SAH. Forty-four percent of SAH
patients had parenchymal lesions in follow-up MRI and
most of these were aneurysm-related. Aneurysm-related
infarctions were detected in 25% of SAH patients and all
were detected during acute treatment period. Only two
patients with unruptured aneurysms had aneurysm-related
infarctions after the treatment period.
Because of the voluntary nature of the imaging study, we
were only able to study 82% of included patients with
follow-up MRI. Those we could not reach may be in
poorer clinical condition and unable or unwilling to partici-
pate. It is thus likely that there is selection bias in our study
and SAH patients may have a higher prevalence of parench-
ymal lesions than our 44%. Earlier reports have documented
infarction rates of 57% (10, 11).
In follow-up images it is difﬁcult to assess the cause of
infarction and for this reason we classiﬁed lesions as par-
ental artery territory or non-parental artery related. Taking
into account only infarctions in parental artery territory,
our ﬁgure of 19% compares favourably with earlier
studies reporting parental artery territory infarction rates
of 20% to 22% (10, 12). A total of 16% of patients had
lesions caused by ICH, which is slightly lower than in the
series of Koivisto and co-workers (12), who reported a rate
of 25%. Lesions caused by ICH were detected in 22% in
the series of Bendel (10). Unfortunately, in some studies
Table 3. Correlation between infarction prevalence and clinical
outcome
GOS 3 GOS 4 GOS 5
Infarction 4 5 16
No infarction 1 14 24
GOS ¼ Glasgow Outcome Scale
Fig. 6 Fluid-attenuated inversion recovery image shows retractive lesion in
the left temporal lobe caused by intraparenchymal haemorrhage from a rup-
tured medial cerebral artery aneurysm
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patients with ICH were excluded. Incidence of infarctions
not related to aneurysm territory in SAH patients was
similar to that reported in earlier studies (10, 12).
To the best of our knowledge, there are no studies on
infarctions long after embolized unruptured aneurysms.
Patients with unruptured aneurysms had parental artery ter-
ritory infarctions during the treatment period in 12% of
cases, which compares favorably with earlier studies (20,
24). Late parental artery territory infarctions were uncommon
although occlusion grade was incomplete in 36% of cases.
Small, high signal foci in the white matter are common
incidental ﬁndings in T2-weighted images. As many as
79% of neurologically healthy people over 55 years have leu-
koaraiosis in MRI (25). In earlier reports, the frequency of
leukoaraiosis in SAH patients was between 32–60% (8, 10,
11). In our study leukoaraiosis was present in 50% of SAH
patients and 28% of patients with unruptured aneurysms.
The clinical relevance of these small incidental ﬁndings
remains unclear.
Clinical symptoms of ischemia were detected during the
treatment period in all SAH patients who developed a par-
ental artery territory infarction. Two out of six patients with
unruptured aneurysms did not have any symptoms of
ischemic episode during the treatment period and infarcts
after the treatment period were related to coil migration,
stenting procedure or giant aneurysm. Despite infarctions
in unruptured patients, treatment of unruptured aneurysms
did not cause permanent deterioration in outcome.
Bryan et al. reported that fewer than half of patients with
cerebral lesion caused by SAH or its treatment have symp-
toms of stroke (26). We found higher symptom rates for
SAH patients, of whom ﬁve out of 14 (36%) were asympto-
matic. Four patients (29%) had global deﬁcits and ﬁve
patients (36%) had focal deﬁcits. Patients with unruptured
aneurysms were more often asymptomatic than SAH
patients. Global deﬁcits were not associated with unrup-
tured aneurysms. Seventy per cent of patients with unrup-
tured aneurysms were asymptomatic and 30% had focal
deﬁcits. Although SAH patients had more symptoms of cer-
ebral infarctions, GOS was not lower than in the group with
unruptured aneurysms. Actually, patients with unruptured
aneurysms had poorer outcome but the difference was not
statistically signiﬁcant. The reason for this poorer outcome
may be that depression was more common in the group
with unruptured aneurysms. It is important to note that
sample sizes in both groups were small and cannot be gen-
eralized in a straightforward manner to all aneurysm
patients. Our outcome measure, GOS, may be too crude to
measure outcome as reported in earlier studies (11, 27). In
addition to primary analyses with GOS, we did some sec-
ondary analyses with the Extended Glasgow Outcome
Scale (GOSE) (28). However the results were similar and
patients with unruptured aneurysms had lower GOSE
than SAH patients. In addition to small sample sizes there
are other limitations in our study. Patient population is
selected and infarction rates might thus be too low. MRIs
in the acute hospitalization period were not done for
every patient. Patients with ruptured and unruptured
aneurysms had differences in population characteristics
and cannot be compared in a straightforward manner.
This was a retrospective series and embolization tech-
nique has subsequently developed a lot. The aneurysms in
our series were treated before the advent of newer tech-
niques such as balloon-assisted remodeling or 3-
dimensional GDC. These new techniques improve occlusion
grades and probably also decreases complication rates.
In conclusion, 19% of patients with unruptured and 41%
with ruptured aneurysms had aneurysm-related parenchy-
mal lesions in MRI. Most of these were detected during
acute treatment period. Aneurysm-related infarctions after
treatment period are uncommon.
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ABSTRACT 
Background and Purpose SAH patients have an excess mortality proportion in long-term outcome 
studies because of the high rate of cerebrovascular and cardiovascular deaths. The aim of the 
present study was to assess the excess long-term mortality among patients with unruptured 
aneurysms with no previous SAH and to compare mortality after coiling, clipping and without 
treatment.  
Methods 291 patients with 379 unruptured aneurysms were admitted to our hospital between 1989 
and 1999. Patients with previous SAH were excluded (151) leaving 140 patients with 178 
unruptured aneurysms as the study population. The patients were followed up until death or the end 
of April 2011. Causes of death were determined. Relative survival ratios (RSR) were calculated and 
compared with the matched general population. 
Results Mean follow-up time was 13 years (range 1-19). During the follow-up period, 50 patients 
(36%) died. Death was caused by cerebrovascular event in almost half of cases (24 out of 50, 48%). 
There was 12% excess mortality at 15 years (cumulative relative survival ratio (RSR): 0.88, in 
males and 35% excess mortality in females (RSR: 0.65). Mortality among females over 50 years 
was significantly higher than among males (p=0.018). 
Conclusions Patients with untreated unruptured aneurysms have excess long-term mortality 
compared to general population. Males with treated unruptured aneurysms have a survival 
proportion comparable to general matched population. Females, instead, have excess mortality after 
both surgical and endovascular treatment of unruptured aneurysms. 
 
Keywords: Unruptured intracranial aneurysm, mortality, outcome, risk of death, relative survival 
ratio 
 
Mortality after aneurysmal subarachnoid 
haemorrhage (SAH) remains high in spite of 
the treatment methods developed. Overall 
case fatality rates have been shown to be 
between 33% and 77% at 1 year after 
bleeding with only slightly decreased in-
hospital mortality from 1986 to 2001.[1-12] 
Even patients with successfully treated  
ruptured aneurysms and good outcome 1 year 
after bleeding have an excess mortality rate in 
long-term outcome studies.[13-15] General 
cerebrovascular and cardiovascular causes of 
death are higher among SAH patients than in 
general population.[12-13,15] However, long-
term mortality in patients with unruptured 
aneurysms is not well studied inspite of 
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increasing number of incidentally discovered 
and aggressively treated aneurysms. The 
management of unruptured aneurysms is 
controversial because the risk of treatment is 
thought to be greater than the risk of 
rupture.[16] Thus our aim was to assess 
excess long-term mortality among patients 
with unruptured aneurysms. 
METHODS 
Patients  
Our hospital serves as a primary and 
secondary care centre for patients with 
intracranial aneurysms, with a catchment area 
of ca. 1.2 million inhabitants. Between 1989 
and 1999, a total of 1,294 patients with 
intracranial aneurysms were admitted to our 
hospital. Of these, 1,154 had previous SAH 
and were excluded leaving 140 patients with 
178 intracranial unruptured aneurysms as the 
study population. All patients were followed 
up until death or the end of April 2011 and no 
patients were lost from follow-up. Fifty of the 
140 patients (36%) died, and death certificates 
were obtained from Statistics Finland. The 
study was approved by the Hospital Ethics 
Committee and Statistics Finland.   
 
Table 1. Patient demographics (% in parenthesis) 
Statistical analysis 
Excess mortality of the patients was measured 
by one minus relative survival ratio (RSR). 
The RSR is the ratio of the observed survival 
proportion divided by the expected survival 
proportion of a comparable group of Finnish 
general population matched for sex, age and 
calendar time. The expected survival 
proportions were estimated by Ederer II 
method.[17] Relative survival measured the 
survival experience of the patients corrected 
for competing risks of death. Relative survival 
ratios and 95% CI were estimated by survival 
package SURV3 V.3.01 (Finnish Cancer 
Registry, Helsinki, Finland). Differences in 
relative survival between patient groups were 
tested applying likelihood ratio tests.[18]  
RESULTS 
Patients (65 men and 75 women) were aged 
18-86 years (mean 54) at the time of 
diagnosis of the unruptured intracranial 
aneurysm (Table 1.).  
 
 
 
 
 Males Females  
 No 
treatment 
Embolizat
ion  
Surgery Males 
total 
No 
treatment 
Embolization Surgery Females total P 
Mean age at 
diagnosis 
57.4 49.0 49.6 52.1 64.1 52.5 50.0 54.6 0.1 
Hypertension 13 (57) 7 (30) 8 (42) 28 11 (58) 10 (30) 11 (48) 32 1.0 
Diabetes 1 (4) 1 (4) 1 (5) 3 1 (5) 2 (6) 1 (4) 4 1.0 
Hypercholest
erolemia 
2 (9) 1 (4) 2 (11) 5 1 (5) 1 (3) 2 (9) 4 0.7 
Previous 
stroke 
8 (35) 4 (17) 4 (21) 16 8 (42) 7 (21) 4 (17) 19 1.0 
Anticoagulant 
therapy 
4 (17) 2 (9) 1 (5) 7 5 (26) 4 (12) 3 (13) 12 0.5 
Aneurysm 
with 
neurological 
(mass) 
symptom 
6 (26) 3 (13) 3 (16) 12 7 (37) 8 (24) 5 (22) 20 0.3 
Location         0.5 
Anterior 
circulation 
19 (83) 23 (100) 19 (100) 61 13 (68) 32 (97) 23 (100) 68  
Vertebrobasil
ar 
4 (17) 0 (0) 0 (0) 4 6 (32) 1 (3) 0 (0) 7  
Mean fundus 
size 
15.5 8.2 10.3 11.4 13.2 10.7 12.5 11.9 1.0 
Multiple 
aneurysms 
4 (17) 5 (22) 3 (16) 12 6 (32) 7 (21) 7 (30) 20 0.3 
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 A total of 66 out of 178 aneurysms were left 
untreated. Sixty-four aneurysms were treated 
with endovascular coiling and 48 aneurysms 
were treated surgically. Fifty out of 140 
patients (36%) died during the 1702 patient-
year follow-up period. Eleven patients (8%) 
died from aneurysmal bleeding and 13 died 
due to cerebrovascular disease other than 
SAH. Cause of death in one patient was 
unverified stroke. Nine out of 11 patients who 
died due to SAH had large aneurysms 
(>15mm, mean 24mm) and 6 aneurysms were 
symptomatic. Eleven patients died of 
cardiovascular diseases (22% of deaths), 6 of 
malignancies (12% of deaths) and 8 for other 
causes (16% of deaths). Patients with treated 
aneurysms were less likely to die from 
neurologically related causes than patients 
with untreated aneurysms (32% versus 61% 
of deaths). Cumulative observed survival 
proportions are shown in Figure 1. 
 
Figure 1. Cumulative observed survival 
proportions in males and females. 
The 5-year cumulative RSR was 0.78 among 
male and 0.56 among females with untreated 
unruptured aneurysms, implying 22% and 
44% excess mortality, respectively (Table 2). 
Mortality among treated groups did not differ 
from general population at 5-year follow-up 
period. The 10-year cumulative RSR was 0.80 
in males and 0.49 in females in untreated 
aneurysms. Females had 19% excess 
mortality in embolization group and 8% 
excess mortality in surgical group at 10-years 
follow-up. Such difference was not found in 
males.  
There was 12% excess mortality at 15 years 
in males and 35% excess mortality in females 
compared with the matched Finnish 
population. The 15-year cumulative RSR was 
0.50 among both women and men with 
untreated unruptured aneurysms, implying 
50% excess mortality (Figure 2). 
 
Figure 2. Cumulative observed and expected 
survival proportions in males and females with no 
treatment. 
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Table 2. Cumulative RSR in different treatment groups. 
 
Males with embolized aneurysms had no 
excess mortality compared with the matched 
Finnish male population (Figure 3) and males 
with clipped aneurysms had approximately 
8% excess mortality (Figure 4). However, 
females had excess mortality in all subgroups 
(Figure 1). The 15-year cumulative RSR was 
0.77 in the embolization group and 0.72 in the 
surgical group, implying 23% and 28% excess 
mortality respectively (Figure 3 and 4). 
Excess mortality was related to age and 
mortality among females over 50 years was 
higher than among males. Both genders under 
50 years had 15-year cumulative RSR around 
0.90 but the 15-year cumulative RSR in 
patients over 50 years was 0.91 in males and 
0.49 in females (p=0.018). 
 
 
  
Figure 3. Cumulative observed and expected 
survival proportions in males and females after 
embolization. 
  at 1 year at 5 years at 10 years at 15 years 
NO TREATMENT      
Males (31) Alive 27 19 18 4 
 Cumulative RSR 0.87072 0.77865 0.79619 0.53259 
 95%CI 0.690-0.962 0.570-0.931 0.559-0.992 0.276-0.846 
Females (27) Alive 21 12 10 3 
 Cumulative RSR 0.72735 0.56173 0.49419 0.47843 
 95%CI 0.510-0.878 0.347-0.768 0.282-0.732 0.261-0.743 
EMBOLIZATION      
Males (34) Alive 34 33 30 15 
 Cumulative RSR 1.00988 0.99549 1.00257 1.06370 
 95%CI 0.000-0.000 0.856-1.040 0.834-1.083 0.870-1.168 
Females (17) Alive 16 15 12 10 
 Cumulative RSR 0.94297 0.97004 0.81039 0.76765 
 95%CI 0.721-0.995 0.742-1.023 0.546-0.971 0.496-0.958 
SURGERY      
Males (24) Alive 23 21 20 8 
 Cumulative RSR 0.96374 0.94982 0.95419 0.92089 
 95%CI 0.796-1.000 0.762-1.015 0.745-1.048 0.631-1.080 
Females (14) Alive 14 13 12 8 
 Cumulative RSR 1.00547 0.95945 0.92754 0.72207 
 95%CI 0.000-0.000 0.708-1.020 0.650-1.039 0.428-0.949 
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Figure 4. Cumulative observed and expected 
survival proportions in males and females after 
surgery. 
 
DISCUSSION 
SAH patients have an excess mortality 
proportion in long-term outcome studies 
because of the high rate of cerebrovascular 
and cardiovascular deaths.[12-15] To the best 
of our knowledge there are no studies 
comparing outcomes of patients with clipped, 
coiled and untreated unruptured aneurysms. 
In previous outcome studies of patients with 
unruptured aneurysms, patients have had a 
previous SAH and thus outcome can be 
related to previous SAH, not truly to 
unruptured aneurysms.[19-20] Long-term 
survival among patients with unruptured 
aneurysms has been studied in only one large, 
administrative database study.[21] In that 
study it was stated that survival among SAH 
patients was significantly lower than among 
patients with unruptured aneurysms, but after 
the first-year post clipping, differences in the 
survival rate diminished.[21]  
Britz et al. found that patients with untreated 
unruptured aneurysms were 30% more likely 
to die than patients in the clipped group.[21] 
Our study corroborates this and we found that 
patients with untreated unruptured aneurysms 
had excess long-term mortality compared to 
age, sex and calendar time matched 
population. However, in both studies 
demographic features differed between 
groups: patients with untreated aneurysms 
were older, more likely to be male and had 
more comorbidities. Thus, higher mortality 
among untreated and treated may be 
attributable to bias. However, Britz et al.[21] 
found that survival differed between the 
surgically treated group and the untreated 
group also after controlling for age and 
comorbidities using proportional hazards 
modelling. The question of confounding by 
indication is difficult to assess in our 
retrospective study. Indication for treatment 
or no treatment was not clear and about 150 
out of 380 unruptured aneurysms were left 
untreated in our hospital between 1989 and 
1999. Patients over 60 years were usually not 
treated, likewise patients with numerous 
comorbidities and non-independent status. 
Posterior circulation aneurysms were not as 
often treated as anterior circulation 
aneurysms. Decisions were made individually 
and are difficult to assess retrospectively.  
Our study is the first study to scrutinize all 
death certificates of patients with unruptured 
aneurysms. We found that a majority of 
deaths, 48%, were caused by cerebrovascular 
diseases and one third of deaths were 
aneurysm related, either due to SAH or giant 
aneurysm mass effect. Most deaths (70%) 
were attributable to cerebrovascular and 
cardiovascular diseases supporting the 
hypothesis that aneurysmal disease is part of a 
more generalized vascular disease. Britz et al. 
found that patients with unruptured aneurysm 
who underwent clipping were less likely to 
die from neurologically related causes (2.3%) 
than untreated patients (5.6%).[21] These 
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rates are much lower than in our series with 3 
out of 10 (30% of deaths, 7% of clipped 
patients) and 17 out of 28 deaths (60% of 
deaths, 40% of untreated patients). Mortality 
did not differ significantly between 
endovascular and surgical groups supporting 
the opinion that unruptured aneurysms can be 
coiled or clipped. 
We found, unexpectedly, that females had 
lower RSR than males. Male patients treated 
with endovascular coiling or surgical clipping 
had no statistically significant excess 
mortality compared to general matched 
population. However, females had 20% 
excess mortality in endovascular and 28% 
excess mortality in the surgical group at 15 
years follow-up. It is known that the 
incidence of SAH is higher among females 
than males and females have more often 
multiple aneurysms.[19,22-25] However, 
outcome after SAH has not differed between 
the genders[22] and thus the difference in 
long-term mortality rate is somewhat 
surprising. The reason for this is unclear. The 
study population was small and may lack 
precision. However, in recent studies vascular 
physiology has been found to differ between 
genders and cardiovascular risk increases with 
age more sharply in women than in men.[26-
27] Our finding confirms that there may be 
differences between female and male 
aneurysm patients and further studies with 
larger population are needed.  
CONCLUSION 
Patients with untreated unruptured aneurysms 
have excess long-term mortality compared to 
general population. Males with treated 
unruptured aneurysms have a survival 
proportion comparable to general matched 
population. Females, instead, have excess 
mortality after both surgical and endovascular 
treatment of unruptured aneurysms. 
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Long term outcome after subarachnoid haemorrhage
of unknown aetiology
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ABSTRACT
Background and purpose The aim of this study was to
assess the long term outcome after non-aneurysmal
subarachnoid haemorrhage (SAH).
Methods 1154 patients with SAH were treated in our
hospital between 1989 and 1999. From this patient
population, 97 patients had a non-aneurysmal SAH. All
hospital records and death certificates were studied and
33 patients were examined by MRI and MR angiography
more than 9 years (mean 12 years) after the initial
bleeding.
Results The cohort consisted of 97 patients. Mean
follow-up time was 9 years (range 0e19). During the
follow-up period, 13 patients (13%) died. Four (4%) died
from the initial bleeding less than 5 weeks after the initial
haemorrhage. There was no delayed mortality due to
SAH or subsequent bleedings. MR angiography revealed
no new findings in 33 surviving patients.
Conclusions Excess mortality during the first year after
SAH was higher than 4%, and remained thereafter
comparable with the general population. There were no
rebleedings and MR imaging did not reveal any vascular
pathology that could explain the earlier SAH.
INTRODUCTION
On average, in 15% (5e30%) of patients with
spontaneous subarachnoid haemorrhage (SAH), no
obvious source of bleeding can be demonstrated,
even with high quality four vessel cerebral digital
subtraction angiography (DSA).1e8 The cause of
angiogram negative SAH has not been established
but a venous or capillary source, ruptured perfo-
rating artery, low ﬂow vascular malformation and
short segment arterial dissection have all been
postulated.9e11 Some researchers do not accept this
and speculate that spontaneous thrombosis, vaso-
spasm, destruction of the aneurysm by haemor-
rhage, narrowing of the aneurysmal neck,
alterations in blood ﬂow, inadequate angiographic
technique or observer error may be responsible.2
Outcome of angiogram negative SAH is good in
90% of cases.4 7 8 12 13 However, many groups
report non-speciﬁc symptoms such as headache,
neuropsychological deﬁcits or depressive symptoms
in up to 62% of patients.14e16 The rebleeding rate is
approximately 5% (0e10%)7 8 15e18 and the risk of
death in non-aneurysmal bleeding has been esti-
mated to be 0e15%2 4 7 8 12 13 15 17 18 Greebe and
Rinkel15 concluded that patients with an angio-
graphic negative perimesencephalic pattern of SAH
have a normal life expectancy but Hawkins et al17
found the cumulative proportional survival after
22 years to be 69% compared with an expected
survival of 89% in patients with SAH of unknown
aetiology.
To the best of our knowledge there are no studies
analysing intracranial arterial status very long after
initial bleeding or that have reported the incidence of
de novo aneurysms in patients having SAH of
unknown aetiology. The aim of this study was to
assess long term outcome after non-aneurysmal SAH.
METHODS
Patients
Our hospital serves as a primary and secondary care
centre for patients with SAH, with a catchment
area of more than 1 million. Between 1989 and
1999, a total of 1154 patients with symptoms and
signs of spontaneous, non-traumatic SAH were
admitted to our hospital. Of these, 97 (8.4%)
patients were included in the study because the
aetiology of the SAH could not be veriﬁed by
repeated four vessel cerebral angiography or post-
mortem examination. SAH was diagnosed by CT
in 80 (82%) cases and by a blood positive lumbar
puncture in 17 (18%) cases. The diagnosis ‘SAH
NOS’ was based on DSA in 96 patients and post-
mortem examination in one patient. All hospital
records were studied and the latest outcome of
patients was evaluated from the most recent notes
in the hospital records or by telephone interview.
Clinical status at the time of the bleeding was
assessed according to the Hunt and Hess scale.19
Glasgow Outcome Scale (GOS)20 was used to
evaluate clinical status at the time of discharge
and at follow-up visits. Primary CT images were
re-evaluated to assess Fisher grades and the presence
of hydrocephalus. All angiograms were reviewed
independently by a neuroradiologist, neuro-
interventionalist and neurosurgeon. Thereafter, the
results were reviewed and a consensus statement
for each study was produced. Surviving patients
resident in our hospital catchment area were
contacted, offered an MRI examination and inter-
viewed to assess clinical outcome and possible
rebleeding episodes. A total of 33 were studied with
MRI and MR angiography (MRA), and interviewed
at our outpatient clinic. Follow-up MRI and MRA
were compared with the ﬁndings of earlier studies.
Surviving patients not studied with MRI lived
outside our hospital catchment area, did not
answer our letter, were unwilling to participate in
the study or had contraindications to MRI. Two
surviving patients were lost to clinical follow-up.
Thirteen of 97 patients died, and death certiﬁcates
were obtained from Statistics Finland. The study
was approved by the Hospital Ethics Committee
and Statistics Finland.
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MRI protocol
The follow-up MR imaging was performed with the 1.5 T unit
(GE Signa HD, Milwaukee, USA) with one channel head coil.
MRA was supplemented with cross sectional imaging, including
ﬂuid attenuation inversion recovery, and T1 and T2* sequences,
mainly to identify ischaemic parenchyma, ascertain the size of
the CSF spaces and persisting blood degradation deposits. The
imaging parameters for the non-contrast three-dimensional time
of ﬂight angiography were: TR 30, TE 2.5, FOV 22316.5 cm, slice
thickness 1.0 mm/interpolated to 0.5 mm, matrix 3203224.
Magnetisation transfer contrast and ﬂow compensation were
included.
Statistical analysis
Statistical analysis was performed using NCSS (NCSS, Kays-
ville, Utah, USA) statistical software. Categorical variables were
compared using the Fisher exact two tailed test. The level of
signiﬁcance was set at p<0.05. Excess mortality of the patients
was measured by one relative survival ratio. The relative survival
ratio is the ratio of the actuarial observed survival rate divided by
expected survival rate of a comparable group of patients from
the Finnish general population matched by sex, age and calendar
time. Relative survival measures the survival experience of the
patients corrected for competing risks of death. Relative survival
ratios were estimated by survival package SURV3 V.3.01
(Finnish Cancer Registry, Helsinki, Finland).
RESULTS
Patients were aged 21e76 years (mean 52) at the time of
bleeding. There were 35 men and 62 women. Most patients had
a good clinical status on admission (table 1). In the deceased
group, patients had a poorer clinical status and higher Fisher
grades on primary CTcompared with the surviving group. There
was no other statistically signiﬁcant difference between the
surviving and deceased groups.
Thirteen of 97 patients (13%) died during the 868 patient-year
follow-up period. Four (4%) died from the initial bleeding of the
non-aneurysmal SAH: two immediately and two patients in
1 month after a poor clinical state. All four patients had severe
bleeding on the initial CT (Fisher 3 or 4, non-perimesencephalic
type of bleeding). Three patients died of cardiovascular diseases,
three of malignancies and three due to traumatic causes.
Mortality in the ﬁrst year after bleeding was more than 4% in
excess of that expected in a comparable group from the general
population, both among women and men. Thereafter, mortality
of the patients was close to the level in the general population.
There were no rebleedings. Ninety-four per cent of the surviving
group (79/84) had recovered well (GOS 4 or 5) and the reason for
the lower GOS was related to SAH in only two (2%) patients
(ﬁgure 1). There was no difference in outcome between patients
studied with and without MRI.
Thirty-three patients were studied with MRI. Mean follow-up
time was 12 years (range 9e18). No new aneurysms were
detected in MRA images or any other vascular pathology that
could explain the previous bleeding. Six patients (18%) had
infarctions in MRI. Two were already seen during the treatment
period after clinically and radiologically proven vasospasm. Four
infarctions were not detected in earlier images and only two of
those four patients had been treated for clinical stroke.
Leukoaraiosis was seen in 11 (34%) patients. Signs of superﬁcial
haemosiderin were present in two patients (6%).
DISCUSSION
After SAH, initial angiographic ﬁndings are negative for
a bleeding source in approximately 15% of patients.1e8 A
traditional concept states that angiogram negative SAH carries
a more benign prognosis than aneurysmal SAH. However, some
patients experience morbidity and mortality because of recur-
rent haemorrhage or vasospasm.14 21e23 Repeat DSA within
2 weeks after the bleeding is commonly performed. Although
repeat DSA provides identiﬁcation of the source of bleeding in
up to 20% of cases, the source remains undetected in the
majority of patients.22e24 The incidence of angiogram negative
SAH was 8.4% in our series and this concurs with recent
series.1e8
We found no new arterial vasculopathies or other aetiologies for
previous SAH in those 33 patients studied. It is a weakness of our
study that we performed MRI in only 34% of patients. However,
those surviving patients we could not reach had a poorer clinical
status and we believe that this selection bias is unlikely to inﬂu-
ence the MRI ﬁndings. Infarctions were detected in six (18%)
patients, which is signiﬁcantly less than in patients with aneu-
rysmal SAH.25e27 Two infarctions were caused by vasospasm and
Table 1 Population characteristics
Surviving group (n[84) Deceased group (n[13)
Mean age (years) 52 53
Sex
Male 31 4
Female 53 9
Diagnosis
CT 67 13
Lumbar puncture 17 0
Fisher
1 16 0
2 17 4
3 20 5
4 23 4
Hydrocephalus 30 4
Hunt and Hess
I 40 2
II 32 2
III 10 5
IV 1 3
V 1 1
GOS at discharge
I 0 2
II 0 1
III 10 1
IV 41 7
V 33 2
GOS, Glasgow Outcome Score.
Figure 1 Present Glasgow Outcome Score (GOS) of patients with
subarachnoid haemorrhage of unknown aetiology.
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two were incidental ﬁndings. Leukoaraiosis was seen in 11 (34%)
patients and this was less than in aneurysmal SAH patients and
not more than the prevalence in a neurologically health age
cohort.25e28 Earlier studies of angiogram negative SAH have
reported a subsequent bleeding rate of up to 10%.7 8 17 18 29
However, the latest reports have detected no rebleedings and
neither did we.15 16
The outcome is much better in SAH patients with unknown
aetiology than in aneurysmal SAH patients.2 4 7 8 12 13 15 17 18
Eighty-one per cent of patients had recovered well (GOS 4 or 5)
and poor outcome was related to SAH in only six (6%) patients
in our series. The risk of death from non-aneurysmal bleeding
has been estimated to be 0e15%.2 4 7 8 12 13 15 17 18 In our series,
4% of patients died of angiogram negative SAH. Overall
mortality in our series was 13% compared with 47% mortality
in aneurysmal SAH patients in our hospital at the same time.30
In the long term outcome study, patients with SAH of unknown
cause had reduced life expectancy compared with expected
numbers.17 However, in that study, as many as 22% of all SAH
patients had no cause on angiogram, which was not repeated,
raising the suspicion that aneurysms were missed. Greebe and
Rinkel,15 however, found no difference in mortality between the
general population and patients with a perimesencephalic
pattern of non-aneurysmal SAH. This study was, however,
involved only a subgroup of all patients with SAH of unknown
aetiology and to the best of our knowledge our study is the only
one in the modern imaging modality era to assess the long term
outcome of patients with SAH of unknown aetiology.
CONCLUSION
Excess mortality during the ﬁrst year after SAH was higher
than 4%, and remained thereafter comparable with the general
population. There were no rebleedings and MR imaging did not
reveal any vascular pathology that could explain the previous
SAH. Based on our results, long term follow-up is not needed,
and after appropriate angiographic studies, patients should be
informed about the benign nature of this rare type of SAH.
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